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Group D snake venom prothrombin activators are structurally and functionally 
similar to blood coagulant FX. As a representative of group D venom 
prothrombin activator, trocarin D from the Tropidechis carinatus venom activates 
prothrombin to thrombin by cleaving the same sites under same conditions in 
comparison to blood coagulant FX. In terms of structure, trocarin D also shares 
the identical domain architectures with blood coagulant FX. Despite such 
similarities, trocarin D and blood coagulant FX play different physiological roles, 
which are attributed to their distinct expression patterns. Trocarin D is specifically 
expressed at high levels in the venom to function as a toxin. While blood 
coagulant FX is liver-specifically expressed at a low level to maintain 
haemostasis. In the body of T.carinatus snake, both prothrombin activator 
systems (trocarin D and TrFX) exist, and they are encoded by two individual 
genes.   
Comparison of the gene structures has shown the gene sequences of trocarin D 
and TrFX are highly similar, except for the promoter and intron 1 regions. In the 
promoter region of trocarin D, there is a 264 bp insertion compared to TrFX, 
which is named as VEnom Recruitment/Switch Element (VERSE). VERSE was 
shown to account for elevated but not venom gland specific expression of trocarin 
D. Hence the insertions/deletions in intron 1 were proposed to silence trocarin D 
expression in non-venom gland cells.  
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Compared to the intron 1 of TrFX, trocarin D has three insertions and two 
deletions. Among all the insertions/deletions, insertion 2 (1975 bp) of trocarin D 
intron 1 compared to TrFX represses gene expression in three mammalian cell 
lines. Within insertion 2, a 209 bp fragment (Ins 2.2.4.) can almost completely 
silence the gene expression. Hence, this suggests that Ins 2.2.4 contains the 
strongest silencing cis-elements to repress trocarin D expression.  Using a series 
of deletions and site-directed mutation studies, Ins 2.2.4 has been shown to 
contain multiple silencing cis-elements that turn off gene expression 
synergistically. Analysis of Ins 2.2.4 sequence characteristics has revealed that 
multiple AG-rich motifs located in this region. The synergism between two AG-
rich motifs is essential for silencing function.  
In addition, these AG-rich motifs are found to be important for specific DNA-
protein complex formation, shown by EMSA competition experiments. By using 
DNA affinity chromatography and mass spectrometry, several silencer binding 
transcription factors (TFs) were identified. The identified TFs are confirmed to 
present in the specific DNA-protein complexes by EMSA-SDS PAGE-Western 
blot experiments. And we also confirmed the functional relevance of these TFs in 
gene repression using siRNA knockdown experiment. The findings highlight the 
importance of AG-rich motifs in regulating venom gland-specific expression, and 
will contribute to understanding the transcriptional repression mechanisms of 
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1.1 A brief introduction  
Snake venoms are complex cocktails of enzymes, peptides and organic molecules. 
Among them, the enzymes and peptides are the most abundant components, 
which usually act on major physiological systems or tissue types accessible by the 
blood stream of the preys, predators, or competitors, such as neurological, 
haemostatic, cardiovascular, and gastrointestinal systems. Disruption of the 
regular functions of these systems by venom proteins causes pain or death in the 
envenomated animal. It is hypothesized that some snake venom toxins are 
recruited through duplications of the genes of physiologically important proteins 
that undergo mutations that give rise to their toxic characteristics. For example, 
venom toxins are exclusively expressed in venom glands to target other animals. 
Recently, this process was shown to be complex and dynamic (Casewell et al., 
2012), during which some venom toxins were reversely recruited from venom 
gland to express in the normal tissue. To fully understand the dynamic change of 
venom toxins expression patterns, gene organization comparisons for snake 
venom toxins and their physiological homologs need to be characterized. Our 
laboratory has characterized parallel prothrombin activator genes from Australian 
elapids and observed that these related genes are highly similar except for major 
differences in gene regulatory regions (i.e promoter and intron regions)(Reza et 
al., 2005b). Therefore, these differences are postulated to account for the 
distinctly different expression patterns between venom and body prothrombin 
activators: venom prothrombin activators are exclusively highly expressed in 
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venom glands, but body prothrombin activators are constitutively expressed at 
low levels in other tissues (Reza et al., 2007). Studies of the differences in the 
promoter regions have shown that this genetic difference is responsible for the 
elevated expression level in the venom glands (Kwong et al., 2009). Hence, it is 
postulated that differences in intron regions are important for controlling the 
expression of venom prothrombin activators in venom gland (Kwong et al., 2009).  
In this chapter, I will first describe gene duplication and recent snake venom 
evolution studies. During the evolutionary processes, changes occur in gene 
regulation of the duplicated gene, which in turn influences its transcriptional 
regulation, and results in changes in expression patterns. For these reasons, 
transcription and its regulatory mechanisms will also be discussed. Since this 
thesis focuses on exploring the transcriptional control of trocarin D (TroD) to 
understand how this venom protein elicits venom gland specific expression 
patterns (different from its body blood coagulation factor counterpart), I will also 
introduce the work which has been done previously in our laboratory to establish 
the evolutionary relationship between these two proteins.  
1.2 Gene duplication 
As an important way to form novel protein-coding genes, gene duplication gives 
rise to redundant duplicate genes. One of the pair of genes may acquire new 
functions via modification or mutation processes to acquire a novel function, 
thereby becoming a new gene (Ohno, 1970). This provides a species new genetic 
material for the future adaptation which may give a reproductive advantage or 
allow the species to survive when its environment changes. For example, the 
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cortical developmental gene Slit-Robo Rho GTPase-activating protein 2 
(SRGAP2) has been shown to have duplicated three times exclusively in humans. 
One of its duplicated copies, SRGAP2C, encodes a functional protein for 
developing bigger brains and inhibiting its other paralogs, is most fixed in humans, 
which suggests that SRGAP2C has contributed to the evolution of the human 
neocortex and is important for human brain development (Dennis et al., 2012).  
1.2.1 Mechanisms of gene duplication 
Basically there are four known mechanisms underlying different types of gene 
duplication: (1) replication slippage, (2) unequal crossing over, (3) retroposition, 
and (4) chromosomal duplication. In the event of replication slippage, DNA 
polymerase is disengaged from the strand undergoing replication and then 
reattaches at a wrong site with similar sequence (Patthy, 2009) . This process 
usually produces very short intragenic duplications. With unequal crossing over, 
recombination happens on misaligned regions between homologous chromosomes 
and gives rise to two different recombinants: one site is duplicated and the other 
site is deleted. Depending on the distance between the two sites involved in 
recombination, the duplicated region can be a partial gene, a complete gene, or 
multiple genes. In the cases of replication slippage and unequal crossing over, the 
duplicated regions are often located in tandem with the original ones. In the event 
of retroposition, the messenger RNA (mRNA) of the duplicate region is reverse 
transcribed into complementary DNA (cDNA) that then randomly inserts into the 
genome. The genomic sequences that have been derived from a reverse 
transcribed cDNA of a gene are processed sequences, meaning they usually have 
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no promoter or intron regions but might have a poly T region. Unlike replication 
slippage and unequal crossing over, in retropositioning the location of the 
duplicated region is always unrelated with the original one. In the event of 
chromosomal duplication, a daughter chromosome does not lose junction after 
DNA replication during meiosis. Depending on the number of chromosomes with 
nondisjunction, the duplicates can be one chromosome or even whole genome 
(Patthy, 2009).  
1.2.2 Fate of the duplicated gene 
After gene duplication, the new duplicates will typically cause either increased 
amounts of the original proteins or novel diversified functions after acquiring 
mutations in functionally important region of the original gene. This functional 
diversification of the new duplicates can occur via the following mechanisms: (1) 
accumulation of coding sequence changes, which may have an effect on resulting 
protein binding interactions and/or catalysis, (2) evolution of splice variants, or (3) 
changes of the protein product expression pattern. Depending on whether these 
changes are advantageous, deleterious or neutral, they are maintained in the 
genome or end up being deleted under a strong selection pressure (Nei et al., 
1997). A duplicate that is maintained in the genome can become a gene with no 
function (pseudogenization), with a conserved parental function, with a partial 






Depending on the duplication mechanism, pseudogenes are called processed 
pseudogenes or unprocessed pseudogenes. The processed pseudogenes are 
duplicated by retrotransposition, and there are several reasons why they become 
non-functional. First, the process of reverse transcription is not as accurate as 
DNA replication, and many mutations between the mRNA and the cDNA can 
occur by which the correct genetic information will be missing. Second, as the 
gene duplicated by retrotransposition contains only the transcribed mRNA 
sequence, it usually does not contain the essential regulatory elements within 
promoter and intron regions. Hence, it will not recruit the transcription machinery 
for gene expression. Third, since the processed gene can be randomly inserted 
into any genomic location, the new location may not have the suitable local 
transcriptional regulatory elements for its expression. However, when the 
insertion occurs downstream from a promoter region, the duplicate gene can be 
transcribed and expressed (Long, 2001). Unlike processed pseudogenes, 
unprocessed pseudogenes duplicated by other mechanisms, which are selectively 
neutral or deleterious, become nonfunctional due to accumulated mutations that 
cause frameshifts, stop codons, or other inactivation of gene expression (Patthy, 
2009).  
1.2.2.2 Conservation of parental function 
It may be beneficial for an organism to maintain a duplicated gene when more 
protein or RNA product gives a selective advantage. For example, if an organism 
is exposed to a toxic environment, it will be selectively advantageous to produce 
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proteins that can decrease the toxicity. One mode of evolution for a duplicated 
gene to maintain its parental function is concerted evolution. In this process, 
frequent gene conversion makes the duplicate share very similar sequence and 
function as the original copy. Another mode of evolution is strong purifying 
selection which removes a mutated gene that functionally diverges from the 
parental form.  
One of the well-studied examples of this includes histone genes with multiple 
identical copies present in the eukaryotes. In birds and mammals, the copy 
number of histone genes is about 10-40 per genome, in Drosophila melanogaster 
it is about 100, and in some sea urchin species it could be 300-600 (Stein and 
Stein, 1989). This is advantageous under selection pressure because large amounts 
of histones are useful at certain points during the cell cycle (Patthy, 2009). 
1.2.2.3 Subfunctionalization 
Unless extra products of the duplicated genes are useful, it is unlikely for a 
genome to maintain extra copies because of the unnecessary cost (Zhang, 2003). 
Hence, subfunctionalization is one mechanism that reduces the redundancy of 
extra copies by complementarily removing part of the parental function. The gene 
usually keeps partial binding interactions, alternative splice forms, and other 
functional aspects and/or changes the expression sites.  
One example of subfunctionalization is a digestive RNase gene from a leaf-eating 
monkey, Pygathrix nemaeus. The leaf-eating monkey has parallel RNases in its 
body, which evolved by gene duplication from a common ancestor with both 
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digestive and double-stranded RNA degradation (EAdsRNA activity) activities. 
After gene duplication and evolution, one RNase, RNase1B, kept only the 
digestive activity in the small intestine to break down RNAs of symbiotic bacteria. 
However, the other one, RNase1, only kept the EAdsRNA activity to degrade 
double-stranded RNA, an activity which might be important for denfense aginst 
viral infection (Zhang et al., 2002).  
1.2.2.4 Neofunctionalization 
One of the most important evolutionary outcomes of gene duplication is the 
development of novel functions. The novel functions could be the development of 
de novo binding sites. But the most common is the modification of the existing 
binding site, hence changing the ligand specificity, affinity, and/or developing 
interactions with novel partners.  
An example of neofunctionalization is prodided by the visual pigment protein 
genes. The green- and red-sensitive photoreceptor proteins are encoded by two 
closely-related and linked genes on the X chromosome in Old World monkeys, 
whereas in New World monkeys there is only one X chromosome-linked pigment 
gene. This indicates that the green and red-sensitive pigment genes evolved by 
gene duplication in humans, apes and Old World monkeys. After duplication, a 
few amino acid substitutions (15 of 348) occurred which resulted in a shift in the 
maximum absorption wavelength.  Due to this, humans, apes and Old World 
monkeys have a wider range of color discrimination, which could provide a 
significant advantage for detecting predators, foods, etc (Yokoyama and 
Yokoyama, 1989).  
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1.3 Convergent and dynamic recruitment of proteins into snake venom 
It has been previously shown that many proteins in snake venom are structurally 
and functionally related to normally-functioning physiological proteins (Fry, 
2005). Phylogenetic analysis of venom proteins and body proteins from multiple 
mammals and birds tissues indicates that the venom protein genes have been 
recruited from duplicated genes of body proteins into the venom gland for 
selective expression (Fry 2005). Once a particular duplicated gene copy has been 
recruited into the venom gland, this gene evolves via the 'birth-and-death model' 
for protein evolution. In this process, a multi-locus gene family is created by 
further gene duplication events, and then duplicated genes diverge by subsequent 
mutation and selection.  
Under selection pressure, some duplicated genes are maintained in the genome for 
a long time, whereas others are deleted or become pseudogenes (Fry, 2005; Nei et 
al., 1997). As described in the previous section, the duplicated toxin genes, which 
are maintained in the genome, usually acquire mutations to undergo neo- and/or 
sub-functionalization This facilitates the toxins to exhibit diverse functional 
activities and new expression site as we see in the venom, which are essential 
characteristics for toxins (Fry, 2005; Fujimi et al., 2002a; Jeyaseelan et al., 2000; 
Joseph et al., 1999; Reza et al., 2006, 2007; Tamiya and Fujimi, 2006).  
1.3.1 Convergent recruitment of snake venom toxins 
Even though snake venom proteins are recruited at different times from a broad 
range of body proteins with diverse ancestral structures and functions, venom 
proteins show a remarkable convergence in two aspects. One is their conserved 
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physiological targets on the host (prey, predator, competitor), and the other is the 
relatively small number of basic molecular building scaffolds (Fry, 2005; Fry et 
al., 2008). Targets of snake venom action include fundamental biochemical 
processes involved in important physiological processes such as nervous system 
and circulatory system (Casewell et al., 2013). Previous studies revealed that 
these reactions are evolutionarily conserved across the kingdom Animalia (Fry, 
2005). This provides the functional basis for a venom protein to elicit its toxicity 
by performing as an exogenous substitute for the endogenous protein from the 
host through one of the following mechanisms: i) catalyzing the hydrolysis of a 
universally present substrate to cause structural damage; ii) resembling 
endogenous body proteins in order to increase concentrations and  cause a 
physiological imbalance; iii) mimicking endogenous physiological proteins and 
targeting the same receptors to competitively inhibit physiological responses (Fry, 
2005).  
One example of venom proteins causing physiological imbalance are provided by 
the snake venom prothrombin activators. In the host, snake venom groups C and 
D prothrombin activators resemble the endogenous blood coagulation factor Xa-
Va complex (group C) or simply factor Xa (group D) to cause unnecessary 
prothrombin to thrombin conversion, thereby leading to pathological thrombosis. 
One example of a competitive inhibitor from venom is erabutoxin b, an -
neurotoxin from the sea krait Laticauda semifasciata (Sato and Tamiya, 1971). 
Erabutoxin b antagonizes endogenous neurotransmitters from binding to the 
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nicotinic acetylcholine receptor and disrupts the normal neural transmission 
thereby causing paralysis of the host.  
Regarding the structural convergence of different venom proteins, previous 
studies have shown that 14 venom protein families have been recruited by two or 
more venomous lineages (Fry et al., 2009; Whittington et al., 2008). A common 
structural feature of these venom protein families from functionally different 
multigene families is that they are extensively cysteine cross-linked. This causes 
the molecular scaffolds of proteins to be more stable, and mutations of non-
structural residues are maintained, the result of which is extensive protein 
neofunctionalization.  
However, compared to the intensive studies of the convergent structures and 
functions of snake venom toxins, there is currently a lack of data which might 
inform our understanding of the change of expression sites of toxin genes. It is not 
clear how the venom counterparts evolved from endogenous proteins by changing 
their expression sites from non-venom gland tissues to venom glands, due to a 
scarcity of available snake genome sequences. As more snake genome and 
transcriptome data are available, the knowledge of these perspectives will grow.  
 
1.3.2 Dynamic recruitment 
Previous studies based on anatomy (Jackson, 2003; Vidal, 2002), comparative 
embryology, and developmental genetics (Vonk et al., 2008) show the homology 
of the venom apparatus across the advanced snakes. Hence, it is considered that 
the origin of venom was a single event in the evolution of advanced snakes. Later, 
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studies using phylogenetic analysis of protein, amino acid or DNA sequences 
reconstructed the history of the recruitment of toxins in the venom of the animals, 
also supporting the single early evolution of venom in snakes (Fry 2005, Fry 
2009), in which the recruitment of venom toxins from related body proteins is a 
rare and one-way process.  
However, a study including the non-venom homologues of toxin genes from other 
reptiles and non-venomous snakes, discovered that non-venom homologues 
frequently reside within venom toxin clades via phylogenetic and ancestral-state 
analyses (Casewell et al., 2012). This suggests that some venom protein types can 
be 'reverse-recruited' from the venom gland to other tissues for a physiological 
role, whereas other venom protein types appear to be co-expressed in both venom 
gland and other tissues (Casewell et al., 2012). Although this study revealed the 
unexpected dynamic evolution of venom toxins, the authors generated the 
phylogenetic tree by comparing non-venom homologs from several non-
venomous snake species to the venom genes from venomous species. The 
robustness of such analysis needs to be improved by comparing toxin-related 
transcripts in other tissues of the venomous species with the venom gland 
expressed transcripts.  
Recently, studies using transcriptomic analysis of both venom gland and other 
tissues of the same snake species show that some toxin genes are co-expressed in 
at least one other non-venom gland tissue type, despite most of the toxins only 
being expressed at high levels in venom glands (Junqueira-de-Azevedo et al., 
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2014; Vonk et al., 2013). This partially supports the idea of 'reverse recruitment', 
suggesting that some genes recruited for expression in the venom glands of 
venomous snake ancestors may have come back in non-venom gland tissues and 
perform a physiological role. Alternately, a recent study proposed a 'more 
parsimonious' model with the venom toxin ancestor is expressed in multiple 
tissues including the venom gland. After a gene duplication, one copy restrictedly 
expressed in the venom gland while the other copy kept the original tissue 
expression pattern (Hargreaves et al., 2014). However, this model, called 
restriction model by opposition of the recruitment model, cannot explain the 
shared ancestry of the co-expressed toxin genes with toxin orthologs expressed in 
the venom glands of other species. On the contrary, one strong evidence of 
reverse recruitment identified in Bothrops jararaca tissue transcriptomes is that 
one SVMP gene exclusively expressed in the pancreas actually resides within the 
snake toxin clade (Junqueira-de-Azevedo et al., 2014). This suggests this pancreas 
expressed SVMP gene first evolved to be a venom toxin, subsequently it was 
reverse recruited to express in pancreas, which supports the idea that venom 
recruitment is a dynamic process.  
1.3.3 Changes in expression pattern: a key to understanding the evolution of 
venom toxins and their non-venom homologs  
One key step during the recruitment of a body protein into the venom gland is the 
change in expression pattern (i.e. expression level, spatial and temporal 
expression specificity. Unlike body proteins (non-venom homologs), in which 
expression is constitutive and low, the expression of venom toxins is inducible 
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and high. This is selectively advantageous for venomous snakes mainly for two 
reasons. One is that snakes can stop the expression of toxins and reduce the 
energetic costs of producing venom when the venom gland is full. The other is 
that once the snake ejects venom (the venom gland is emptied), the expression of 
toxic venom components is rapidly initiated and up-regulated to restore sufficient 
amount of toxins in a short time (Currier et al., 2012; Paine et al., 1992)  
Besides these time-specific expression patterns, it has also been shown that most 
venom toxins are selectively expressed in venom glands (Fujimi et al., 2004; 
Junqueira-de-Azevedo et al., 2014; Vonk et al., 2013) maybe due to their potential 
toxicity to the snake itself. In most cases of the co-expression, the level of venom 
toxins in non-venom gland tissues is much lower than that in the venom gland 
(Fujimi et al., 2004; Junqueira-de-Azevedo et al., 2014; Vonk et al., 2013). This is 
likely due to leaky expression(Ramsköld et al., 2009), where the expression level 
of toxins in other tissues is limited so that the toxic effects are tolerated for the 
snakes. In a few cases, the expression level of venom toxins is higher in accessory 
glands than in venom glands (Vonk et al., 2013). However, the mechanism of this 
still not understood.  
Previous studies have focused on phylogenetic comparisons of gene sequences to 
show the evolutionary relationships between the venom toxin proteins and their 
non-venom homologs. However, the findings previously mentioned suggest that 
the distinctions in expression patterns between venom toxic proteins and 
physiological body proteins are more complicated than previously thought. To 
answer why venom proteins are expressed only in venom glands at a high level 
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compared to their non-venom homologs, attention needs to be paid to the genetic 
differences which regulate gene expression. Previous studies have shown changes 
in the promoter region of venom genes, which accounts for their elevated protein 
expression (Fujimi et al., 2004). However, these genetic changes cannot account 
for the spatial and temporal control of venom toxin expression. To completely 
understand the control mechanism of the other two expression aspects, a detailed 
study of transcriptional regulation of venom toxin gene expression is needed. This 
will facilitate understanding how some venom toxins were first recruited from 
physiological proteins and then came back to non-venom gland tissues to perform 
physiological functions (Casewell et al., 2013).  
1.4 Transcriptional regulation in eukaryotes 
Although the DNA content of different tissue types in one eukaryotic organism is 
usually identical, the RNA and protein content of different tissue types in various 
environments can be very distinct. This suggests that the processes whereby DNA 
is transcribed into mRNA (transcription) and mRNA is translated into protein 
(translation) are regulated to alter gene expression (Latchman, 2005). During 
transcription in eukaryotes genetic information in DNA is transcribed by RNA 
polymerases into primary RNA transcripts in the nucleus. These primary 
transcripts undergo modifications (addition of a 5' cap, cleavage, and addition of a 
3’ polyA tail, splicing) and mature as functional mRNA. The functional mRNA is 
then transported from the nucleus to the cytoplasm where it is translated. The 
initial protein is then folded into a functional protein. Theoretically, expression of 
a specific gene in a specific tissue can be regulated at any of these stages. 
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Through these ways, gene expression can be controlled in different tissue types 
under different conditions to undergo needed physiological responses. While 
regulation occurs after transcription as well, most regulation events are mostly 
seen at the transcriptional level (the first step of the process) and not afterwards 
(Latchman, 2005). As this thesis focuses on the trocarin D gene, the regulation of 
which happens at the transcriptional level, this section will mainly describe 
transcription and the mechanism of transcriptional regulation.  
1.4.1 Transcription  
As RNA polymerase II transcribed all the protein coding genes in eukaryotes, this 
RNA polymerase II will be further discussed in this section. Transcription can be 
divided into three events: transcription ignition, elongation and termination. 
1.4.1.1 Transcription initiation 
In eukaryotes, transcription initiation requires a transcription initiation complex 
which comprised transcription factors and a RNA polymerase. These factors help 
the polymerase to bind to a complementary promoter sequence. 
One of the most characterized promoter sequences is the TATA box. The TATA 
box is found approximately 25-30 base pairs (bp) upstream of the transcription 
start site. When a gene containing a TATA box promoter sequence is transcribed, 
transcription factor II D (TFIID, containing TATA-binding protein) initially 
recognizes and binds to this site. Subsequently five other transcription factors 
(TFIIA, TFIIB, TFIIE, TFIIF, TFIIH) and RNA polymerase II assemble around 
this DNA-protein complex and form a pre-initiation complex in a series of steps. 
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One of the recruited transcription factors in particular, with which it can denature 
double-stranded DNA to open the double strands and phosphorylate the C-
terminal domain of the biggest subunit of RNA polymerase II. This allows 
transcription to begin. However, this transcription process is shown to be very 
short in terms of the length of transcripts. Transcription complex pauses after 20-
30 base pairs and is likely to be released just after it exits the promoter (Goldman 
et al., 2009; Hsu, 2002). To continue transcription, further phosphorylation of the 
C-terminal domain is needed to release the block of transcription complex 
(Orphanides and Reinberg, 2002; Sims et al., 2004).  
1.4.1.2 Transcription elongation 
As RNA polymerase II traverses the template DNA strand in the 3' to 5' direction 
and transcribes the RNA from the 5' to 3' direction, it utilizes the non-coding 
strand of the DNA as a template so that the RNA carries the same sequence 
information as the coding strand (Spencer and Groudine, 1990). During 
elongation, a single DNA template can be bound by multiple RNA polymerase II 
units and is transcribed into multiple mRNA transcripts at the same time. In 
addition, a proofreading mechanism is also involved in this process to replace 
mismatched bases (Toulmé et al., 1999; Wang et al., 2009).  
1.4.1.3 Transcription termination 
Transcription termination in eukaryotes usually involves two steps: i) cleavage of 
the primary RNA transcripts and ii) addition of poly-A tails at the 3’ end of the 
RNA. This process is completed by two protein complexes called cleavage and 
polyadenylation specificity factor (CPSF) and cleavage stimulation factor (CstF). 
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During transcription, CPSF and CstF travel together with the RNA polymerase II. 
When they reach the termination signal, CPSF and CstF can recognize the 
conserved sequence elements upstream (AAUAAA) and downstream (G/U) of the 
cleavage site, respectively, and then CPSF and CstF are transferred to the RNA 
transcripts. Following this, CPSF and CstF interact with each other and cleave the 
RNA between the two binding sites. After cleavage, an additional protein poly (A) 
polymerase assembles on this complex and adds a run of approximately 200 
adenosine (A) residues to the free 3' end. It has been shown that the poly-A tail is 
important for protecting mRNA from degradation by exonucleases (Parker and 
Song, 2004) in the nucleus. Once the poly-A tail is added, poly-A binding 
proteins subsequently assemble and regulate the length of the poly-A sequence. 
These poly-A binding proteins remain with the mRNA and are transported out of 
the nucleus to the cytoplasm for protein translation.  In this way, the poly-A tail 
complex regulates the efficiency of translation of mRNA (Tanguay and Gallie, 
1996).  
1.4.2 Regulation of transcription 
Generally, the transcription level of a specific gene at certain environment is 
determined by the transcription initiation rate. In a tissue where a gene is actively 
transcribed, multiple RNA polymerases move along the gene simultaneously, and 
produce a large number of transcripts within a short time. On the contrary, if a 
gene is transcribed at a very low level in a certain tissue, it is uncommon to 
observe the transcription initiation even after a very long time. Besides 
transcription initiation, transcription elongation is also observed to be regulated 
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resulting in a different transcription level in some cases. In this process, the 
transcription elongation can be blocked by regulatory factors and produce a 
truncated transcript.  
Although for many genes in a eukaryotic cell, the basal transcriptional initiation 
and elongation factors are the same, their transcription timing and level can be 
very different. This is mainly determined by the distinct sets of regulatory DNA 
sequences (cis-elements) and their corresponding transcription factors near or 
within a gene. Besides this, the accessibility of transcription factors to cis-
elements is also regulated by the chromatin structure of the region where a gene 
resides. Hence, the next section will describe transcriptional regulations by 
transcription factors, cis-elements, and chromatin structures.  
1.4.3 Transcriptional control - cis-elements 
The cis-elements determine which transcription factors are recruited to the 
regulatory regions of the gene. According to the location and different effects on 
transcription, the cis-elements are classified into these following groups.  
1.4.3.1 Cis-elements with activating activities 
Short sequence elements located within or adjacent to the gene promoter 
These cis-elements are generally located within or adjacent to the gene promoter, 
and they take effect by binding to specific transcription factors which are 
activated under certain conditions. This binding complex activates the gene 
expression in one of the following ways: i) chromatin remodeling by opening the 
chromatin structure and allowing the gene to be accessible for other transcription 
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factors to activate transcription, ii) direct interaction with the basal transcription 
machinery, with which it either stabilizes the transcription complex or increases 
the machinery activity resulting in activation of the gene.  
Enhancers 
Enhancers are a group of cis-elements which can enhance promoter activity 
without the limitations of the distance, orientation and position of this cis-element 
relative to the promoter. In fact, enhancers contain similar sequences compared to 
the short cis-elements located adjacent to the promoter. Nevertheless, instead of 
containing only one short cis-element, enhancers involve a set of different 
regulatory sequences (some are similar to the one present within the promoter and 
some are associated with other regulatory elements, or in multiple copies). These 
multiple cis-elements recruit a set of different transcription factors which function 
together to activate the transcription, also referred as an enhancersome (Merika 
and Thanos, 2001). Similar to the short cis-elements, enhancers also activate 
transcription either by opening the chromatin structure or by direct interacting 
with the transcriptional machinery. There is one model to explain why the 
enhancer activity is independent of its distance relative to the promoter. In this 
model, the proteins bound to enhancer motifs are in contact with the ones bound 
to the promoter by looping out the intervening DNA (Bulger and Groudine, 1999). 
Indeed, it has been shown that certain proteins can bind to the enhancer and bend 
the DNA, making the interaction between distant sites possible (Werner and 
Burley, 1997).  
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1.4.3.2 Cis-elements with silencing activities 
Silencers 
Unlike enhancers, cis-elements called silencers repress the transcription of genes 
which contain or are in contact with them. Silencers are one of the major types of 
negative regulatory cis-elements. They can inhibit the activity of the targeted 
promoter in a distance-, orientation-, and position-independent manner. Similar to 
enhancers, silencers also take effect in two ways: i) recruiting transcription factors 
which regulate the chromatin structure; ii) binding to transcription factors which 
interfere the interaction between RNA polymerases and the associated activators. 
Indeed, some silencer sequences represent nuclear matrix attachment sites where 
the chromatin is most condensed in the nucleus. This suggests that silencers may 
facilitate further condensation of the chromatin to a higher order of structure. 
Besides this, some silencers can also recruit negative regulatory transcription 
factors to directly inhibit the activity of transcription machinery. 
 
Insulators 
As enhancers and silencers can function over a long distance, it is necessary for 
the cell to have a mechanism to prevent them from spreading their effect on the 
inappropriate genes. Insulators are the type of cis-elements which can restrict the 
effect of enhancers or silencers to the insulated regions (Bell et al., 2001; 
Labrador and Corces, 2002; West et al., 2002). Similar with enhancers and 
silencers, insulators achieve their function by binding to specific transcription 
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factors and form a complex. Depending on the exact mechanism with which the 
enhancers or silencers utilize to regulate gene expression, the insulator complex 
confines the action of the enhancers and silencers respectively. If an enhancer or 
silencer changes the chromatin structure over a long distance, the insulator 
complex will prevent the spreading of this change from the region beyond the 
insulator site (Gerasimova and Corces, 1998). If an enhancer acts by looping the 
DNA, the insulator complex will separate the enhancer from the promoter 
possibly by forming smaller loops in the intervening region (Bell et al., 2001).  
Locus control regions 
It is observed that different copies of a same gene (including its promoter and 
adjacent enhancers) could have very different expression levels when they are 
inserted into different regions of the host chromosome. This suggests that the 
adjacent host chromosome region has a stronger impact on the expression of the 
inserted genes than its own promoter. These regions are called locus control 
regions (LCR). Analysis of the DNA sequences in the LCRs shows that they 
contain common motifs with promoter and enhancer elements. However, instead 
of recruiting transcription factors and directly interacting with the transcription 
machinery, the LCRs are more likely to affect their adjacent chromatin structure. 
Consistent with this function, it is shown that the LCR near -globin cluster 
contains DNase I hypersensitive sites and is able to increase DNase I 
hypersensitivity of regions near it during the erythroid early development stage, 
hence, resulting in active transcription (Bulger and Groudine, 1999; Li et al., 
2002).  As the DNase I hypersensitive sites do not form nucleosomes, it is likely 
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that LCRs form a highly supercoiled strand due to the torsional stress, allowing 
them to propagate this torsion to the adjacent region and induce sets of active or 
potentially active DNA.  
1.4.4 Transcriptional control - transcription factors 
As the previous section described, DNA cis-elements influence transcription by 
binding to regulatory proteins, which are known as transcription factors. 
Interestingly, since the DNA cis-elements for a gene is usually the same for all the 
cells in an individual, when and where a gene is transcribed is usually determined 
by the availability of specific binding transcription factors. Hence, this section 
will describe how transcription factors recognize DNA and subsequently regulate 
transcription. 
1.4.4.1 DNA binding by transcription factors 
Eukaryotic transcription factors usually contain multiple domains for DNA 
binding. Some of the domains bind to DNA directly, and the others facilitate the 
DNA binding of the adjacent direct DNA binding domains. According to different 
structural characteristics, the DNA binding domains are classified into different 
groups as shown in Table 1-1.  
1.4.4.2 Regulation of transcription 
Although the DNA binding domains of transcription factors are important, the 
regulatory function of transcription factors are elicited by other domains which 
can either activate or repress transcription. According to their effect on 
transcription, they are indeed classified as transcriptional activators and repressors. 
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Activation of transcription 
The transcription factors can activate transcription either by directly interacting 
with the basal transcription machinery, or indirectly through interacting with co-
activators. To activate transcription, the activator complex stabilize or increase the 
recruitment rate of the basal transcription machinery, or it directly stimulates the 
activity of basal transcription machinery. For transcription activators which have 
the direct interactions with the basal transcription machinery, different 
components of the transcription complex can be targets for different activators. 
For example, acidic activators target TATA-box binding protein (Kuras and 
Struhl, 1999; Li et al., 1999), while proline-rich activators bind transcription 
associated factor II 55 (TAFII55). For transcription activators which are not in 
direct contact with the basal transcription machinery, co-activators are needed to 
mediate transcription activation. To activate transcription, the co-activators not 
only change the basal transcription machinery stability and activity, but also open 
the chromatin structure to facilitate the binding of other transcription factors 
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Thus, by directly or indirectly interacting with the basal transcription machinery, 
the activator complex can stimulate transcription with multiple mechanisms.   
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Repression of transcription 
Other than transcription activators, there are transcription repressors which 
repress transcription when it is not needed. One mechanism for transcriptional 
repressors is that it interfere with the function of transcription activators. This 
interference can be achieved by: i) blocking the activator binding site via 
changing the chromatin structure; or: ii) directly binding to the same DNA site the 
activator recognizes; or: iii) by the activator sequestration in order to prevent the 
binding of the activator to DNA; or: iv) neutralizing the activity of activator by 
binding to an adjacent site to the activator. Instead of interfering with the activity 
of transcriptional activators, other repressors can directly inhibit transcription by 
changing the chromatin structures or destabilizing the basal transcription complex. 
For example, thyroid hormone receptor encoded by mammalian c-erbA gene 
recruits a co-repressor when it does not bind to hormones, and then this complex 
assembles with the Sin3/RPD3 protein complex which condenses the chromatin 
structure by deacetylating histones and results in transcription inhibition (Nagy 
and Schwabe, 2004; Rosenfeld and Glass, 2001). In other cases, such as the 
activators, repressors can destabilize the transcription complex and reduce their 
activity directly or through a co-repressor. Hence, by balancing the activity of 
repressors and activators, the cell can fine tune the gene transcription level under 
different conditions which is essential to maintain its function.   
1.4.4.3 Regulation of the transcription factors 
As mentioned earlier, tissue- and time-specific gene transcription are mainly due 
to the different reservoir and activities of transcription factors in the cell under 
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distinct conditions. Hence, to understand why the transcription factors are only 
functional in specific tissues at specific time, it is important to know how these 
transcription factors are regulated. At this level, the transcription factors can be 
regulated at either the expression level or at the activity level.  
Regulation of expression level 
In some cases, transcription factors are only present or expressed at a high level in 
specific tissues, therefore, their regulatory effects on the target genes can only be 
observed in these tissues. Like other genes, the expression level of transcription 
factors are also regulated at transcription, post-transcription and translation levels. 
One example for this type of regulation is C/EBPa liver-specific transcription 
factor regulating several liver-specific genes such as transthyretin and 
antitrypsin. It was shown that C/EBPonly express at a high level in liver, 
and its expression level is regulated at both the transcription and translation levels 
(Latchman, 2005).  
Regulation of activity 
Unlike the previously mentioned transcription factors which are regulated at the 
expression level, the activities of many other transcription factors are regulated 
either by conformation changes induced by binding of ligands or by post-
translational modifications. One of the advantages for this type of regulation is 
that it will result in a rapid response to the environmental stimulus.  
There are several possible mechanisms for a transcription factor to be regulated 
by ligand binding. The simplest model involves a conformational change in the 
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transcription factor structure after ligand binding which allows the transcription 
factor to interact with the DNA or dissociate from it, and hence resulting in 
different regulatory effects. An “extension” to this model, is observed in the case 
of thyroid hormone receptor. The ligand binding induces a conformational change 
of the thyroid hormone receptor. Instead of directly affecting the DNA binding 
affinity of thyroid hormone receptor, this change leads to the recruitment of a co-
activator which allows the activation of thyroid hormone responsive gene 
expression. In other cases, the stimulus induces conformational changes resulting 
in dissociation of the transcription factors from inhibitor proteins and allow them 
to bind their DNA sites and activate gene expression.  
Besides the conformational changes induced by the binding of ligands, post-
translational modifications such as phosphorylation, acetylation, and 
glycosylation are also important mechanisms which are able to change the activity 
of transcription factors. The post-translational modifications can either activate a 
transcription factor by modulating its ability to stimulate transcription following 
DNA binding, or allow recruitment of other factors which are crucial for 
transcriptional activation to occur. In addition, in some cases, phosphorylation of 
inhibitory proteins contributes to the release of transcription factors and allows 
them to activate gene transcription (Latchman, 2005).   
1.4.5 Transcriptional control - chromatin structure 
In eukaryotes, the DNA is wrapped around specific nuclear proteins and folds into 
a structure called chromatin (Wolffe, 1998). The basic unit of the folded structure 
is called nucleosome and consists of approximately 147 base pairs of DNA which 
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bind a conserved histone protein octamer. The histone protein octamer is 
composed of two molecules of each of the core histones H2A, H2B, H3 and H4 
(Khorasanizadeh, 2004; Zalensky et al., 2002). This structure impedes the 
accessibility of RNA polymerases and transcription factors to the DNA. However, 
the chromatin structure can be dynamically regulated by various mechanisms 
including histone modification, chromatin remodeling, histone variant 
incorporation, and histone eviction. And the resulted different chromatin 
structures will affect the binding of transcription factors as well as the initiation 
and elongation steps of transcription (Li et al., 2007).  
1.4.5.1 Histone modifications and transcription  
There are several types of histone modifications: methylation of arginine (R) 
residues; methylation, acetylation, ubiquitination, ADP-ribosylation, and 
sumoylation of lysine (K); and phosphorylation of serines and threonines. 
Modifications resulting in active transcription are termed euchromatin 
modifications, such as acetylation of histone 3 and histone 4 (H3 and H4) or di- or 
trimethylation (me) of H3K4. Modifications associated with inactive transcription 
are named heterochromatin modifications, such as methylation of H3K9 and 
H3K27. Usually these histone modifications are located in distinct patterns within 
different regions of the gene, such as the upstream region, the core promoter, and 
the 5' and 3' end of the open reading frame. The distinct distribution patterns of 
these modifications are tightly controlled and have crucial effects on transcription.  
Histone acetylation is achieved by histone acetyltransferase complexes  (Brown et 
al., 2000). The number and positions of modified lysine residues determined 
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specific regulation of the genes (Kurdistani et al., 2004). However, methylation, 
phosphorylation and ubiquitination of histones are usually performed by specific 
enzymes at a specific site and cause unique effects. As a consequence, the 
modifications can either change the net charge of nucleosomes (Reinke and Hörz, 
2003; Zhao et al., 2005), which result in loosening of DNA-histone interactions, 
or be recognized by specific proteins that influence chromatin dynamics and 
function (Jenuwein and Allis, 2001; Seet et al., 2006; Strahl and Allis, 2000; 
Turner, 2000).  
1.4.5.2 Chromatin remodeling and histone eviction  
Another major group of chromatin regulators are the chromatin remodeling 
complexes. They hydrolyze ATP and  change the interactions between histone 
and DNA (Saha et al., 2006; Smith and Peterson, 2005). There are several 
activities occurring during the remodeling of chromatin, which need histone 
eviction. Histone eviction is mediated by cooperative transcription factor binding, 
chromatin remodeling complexes such as Swi/Snf and ISWI (Bruno et al., 2003), 
and actively transcribing RNA polymerase II (Kireeva et al., 2002). The histone 
chaperones (Asf1, Nap1, nucleophosmin and nucleolin) prevent the displaced 
histones from rebinding to the same DNA molecules (English et al., 2006; 
Schwabish and Struhl, 2006). As a consequence, the end DNA will be transiently 
unwrapped from the histone octamers, which results in the DNA loop formation 
or moving nucleosomes to a different position (sliding). All of this could change 
the accessibility of nucleosomal DNA to transcription factors.  
37 
 
1.4.5.3 Histone variant incorporation 
Except the core histones which are synthesized during S phase of the cell cycle 
(Kornberg and Lorch, 1999), there are many histone variants which are expressed 
outside of S phase and incorporated into the nucleosome in a DNA replication 
independent manner (Kamakaka and Biggins, 2005). Indeed, the histone variants 
can be integrated into the nucleosome by ATP-dependent histone displacement 
reactions (Mizuguchi et al., 2004), or by histone chaperons, such as Nap1 (Park et 
al., 2005), or through transcription activation (Schwartz and Ahmad, 2005). The 
incorporation of different histones has different effects on chromatin structure. As 
histone variants and canonical histones keep many modification sites (McKittrick 
et al., 2004), they may be recognized by the same chromatin regulatory proteins 
and lead to various regulatory activities.   
1.4.5.4 DNA methylation 
Besides histone modifications, cytosine bases in the DNA can be methylated at 
the position 5. Most of the methylated cytosines occur in the dinucleotide CG. It 
is observed that a number of CG sites can exhibit a tissue-specific methylation 
pattern, which suggests that it may be involved in the tissue-specific regulation of 
gene expression (Christensen et al., 2009; Doi et al., 2009; Irizarry et al., 2009). 
Indeed, some proteins are able to interact specifically with methyl-CpG and are 
important for regulation of gene expression. One example is MeCP2, which is a 
specific protein binding to methylated CG but not to unmethylated ones. As a 
consequence of MeCP2 binding, a multi-proteins complex including a histone 
deacetylase is recruited to the methylated CG site and induces the removal of 
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acetyl groups from histones (Bird and Wolffe, 1999). As the deacetylation of 
histones result in a heterochromatin structure, this MeCP2 bound methylated CG 
leads to transcriptional repression.  
Depending on the above regulatory mechanisms, chromatin structure is 
dynamically regulated at transcription initiation and transcription elongation stage. 
Different stages of transcription are associated with different regulators of 
chromatin structure. Hence, understanding of regulation of chromatin structure is 
important to uncover the mechanisms of transcriptional regulation.  
1.5. Recruitment of trocarin D  
Trocarin D has been characterized to be recruited from an endogenously 
expressed blood factor by a gene duplication process. Previous study has shown 
that the genetic difference in promoter region between trocarin D and its body 
protein homolog contributes to elevate the gene expression level in the venom 
gland cells. This thesis aims to investigate how the differences in intron 1 region 
account for tissue- and time-specificity of trocarin D expression, another 
important feature of a venom gene. This section is to describe the previous studies 
which have established the evolutionary relationship between trocarin D and its 
body protein homolog TrFXa. 
1.5.1 Snake venom prothrombin activators 
Snake venom contains diverse biologically active proteins used as deadly 
weapons to disrupt the vital physiological systems of other animals. One of the 
classical examples is the presence of exogenous prothrombin activators in the 
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venom. Endogenous prothrombin activators convert prothrombin to thrombin, 
which triggers the entire blood coagulation in the presence of phospholipids, Ca2+ 
and FVa. Injection of venom prothrombin activators into other animals causes  
haemostatic imbalance (Gao et al., 2002; Rosing and Tans, 1992; Silva et al., 
2003; St Pierre et al., 2005; Yamada and Morita, 1997).  
Depending on their structures, cofactor requirement and the end-products, venom 
prothrombin activators are divided into four groups ( Kini et al., 2001). Groups A 
and B are metalloproteinases that convert prothrombin to meizothrombin, such as 
ecarin and carinactivase from Echis carinatus venom (Morita and Iwanaga, 1981; 
Nishida et al., 1995; Schieck et al., 1972; Yamada et al., 1996); group C and 
group D are serine proteinases that convert prothrombin to thrombin, such as 
oscutarin from Oxyuranus scutellatus (Speijer et al., 1986) and hopsarin from 
Hoplocephalus stephensi (Rao et al., 2003). Of the four goups, groups C and D 
prothrombin activators are of interest as they are highly similar to the mammalian 
blood coagulation factor FXa–FVa complex and FXa, respectively (Joseph et al., 
1999; Rao and Kini, 2002; Rao et al., 2003; Reza et al., 2005a). 
 Our laboratory has taken pseutarin C from group C and trocarin D from group D 
as representatives and found that their structures and functions are similar to 
mammalian blood coagulation factors. This observation suggests that groups C 
and D prothrombin activators have probably evolved by duplicating the genes 
encoding these blood coagulant factors and accelerated evolution after its 
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1.5.2 Structural and functional similarity between trocarin D (group D 
prothrombin activator) and mammalian blood coagulation factors. 
After notecarin was first identified and characterized from Notechis scutatus 
scutatus venom by Rosing and his colleagues (G Tans, 1985), a group of proteins 
with similar activities were isolated and characterized from other Australian 
elapid snakes. They were later defined as group D prothrombin activators (Rosing 
and Tans, 1992). The group D prothrombin activators comprised glycoproteins 
with a molecular weight around 50 kDa. Functional characterization of these 
proteins showed that they share a striking similarity in activity and cofactor 
requirements with mammalian blood coagulation factor Xa (Table1-2) (G Tans, 




Following these discoveries, trocarin D, a prothrombin activator, is purified from 
the venom of Tropidechis carinatus by systematic protein purification to 
homogeneity (Joseph et al., 1999). Indeed, functional characterization of trocarin 
D has shown that it is functionally similar to mammalian blood coagulation factor 
Xa in the following four aspects: i) both of them convert prothrombin into 
thrombin to promote blood coagulation; ii) the cleavage product of bovine 
prothrombin produced by trocarin D and human FX are identical; iii) the cleavage 
sites on prothrombin targeted by trocarin D and human FXa are also the same 
(Arg 274-Thr 275 and Arg323-Ile324); iv) both proteins require Ca
2+ ion, 
phospholipids and activated FVa for their optimal catalytic activity (Joseph et al., 
1999).  
Despite this functional similarity, trocarin D and mammalian blood coagulation 
factor Xa play different physiological roles for the organisms. As a venom 
component, trocarin D is highly expressed in venom gland for prey capture 
(Joseph et al., 1999; Reza et al., 2005a). Upon envenomation, trocarin D promotes 
pathological blood coagulation and induces cyanosis and death in experimental 
animals (Joseph et al., 1999). However, mammalian blood coagulation factor Xa 
is constitutively expressed at a low level to maintain haemostasis and prevent 
excessive blood loss for the animals. Hence, structural characterization has also 
been done to understand whether these functionally similar proteins resemble one 
another in sequence as well.  
Trocarin D is a protein with two chains linked by a disulfide bond. The complete 
protein sequences of both chains were determined by Edman degradation (Joseph 
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et al., 1999). Compared to the structure of mammalian FXa, trocarin D has 
identical domain structures (Fig. 1-1) and significant sequence similarity (53-60%) 
(Joseph et al., 1999). Similar to human FXa, the light chain of trocarin D contains 
one Gla domain with the same 11 -carboxylated glutamic acid residues and two 
epidermal growth factor like domains (EGF-I and EGF-II). The heavy chain of 
trocarin D has serine proteinase domain with the characteristic catalytic triad 
(His42, Asp88 and Ser185).  
Besides the similar domain structure, trocarin D and human FXa have different 
post-translational modifications (Fig. 1-1). First of all, trocarin D is O-linked 
glycosylated at Ser52 in the light chain and N-linked glycosylated at Asn45 in the 
heavy chain (Joseph et al., 1999). Interestingly, the O-linked glycosylation part 
contains N-acetylglucosamine, which is common in cytoplasmic and nuclear 
proteins but rarely found in secreted proteins (Hanover et al., 1987; Holt et al., 
1987). These glycosylations are proposed to protect trocarin D from proteinase 
and contribute to its thermal stability (Rao et al., 2003). Compared to trocarin D, 
human FX contains two O-glycosylation and two N-glycosylation parts (Inoue 
and Morita, 1993), but they are removed after FX is activated. However, human 
FX has one -hydroxylation site at Asp63 in the EGF-I domain of the light chain 
(McMullen et al., 1983; Stenflo et al., 1987),while trocarin D does not have this 
modification at the corresponding residue (Joseph et al., 1999). Except these 
differences, trocarin D has very similar structural properties as mammalian FXa. 
Similar to trocarin D, other group D snake venom prothrombin activators, such as 
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hopsarin D (Rao et al., 2003), also show significant structural and functional 
similarities to mammalian FXa.  
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Figure 1-1. Domain structure of trocarin D and mammalian FXa. Solid 
diamond represents -hydroxylation; open triangle represents O-linked 
carbohydrate at Ser52; solid triangle represents N-linked carbohydrate at Asn45; 
"Y" represents -carboxylated glutamic acid residues. 
 
1.5.3 Parallel prothrombin activator system in Australian elapids. 
As vertebrates, snakes possess a closed circulatory system with endogenous 
haemostatic factors to maintain the haemostasis. Therefore, T. carinatus has two 
parallel prothrombin activating systems involved in distinct physiological 
processes: trocarin D is expressed in the venom gland and used as a weapon to 
disrupt the haemostatic system of the prey or predator, and TrFX is expressed in 
the liver and activated in the blood to maintain the haemostasis. Therefore, it is 
interesting to identify the sequence similarities of those two proteins and analyze 
their evolutionary relationship.  
44 
 
As blood coagulation factor X is expressed in the liver of T. carinatus, the mRNA 
of TrFX was extracted the liver and reverse transcribed into cDNA to determine 
its sequence (Reza et al., 2005a). According to the deduced amino acid sequence, 
TrFX is 80% similar to trocarin D and 50% identical to mammalian FX (Reza et 
al., 2005a). Compared to trocarin D and other mammalian FX, TrFX contains the 
identical domain structure and cysteine residues for disulfide bond formation. 
Regarding the posttranslational modifications, TrFX is more similar to trocarin D 
than mammalian FX, namely it has similar -carboxylation, N-glycosylation and 
O-glycosylation (Reza et al., 2005a). The presence of trocarin D and TrFX in T. 
carinatus confirms the presence of parallel prothrombin activator systems in this 
snake. Subsequently, it was shown that these two proteins are encoded by two 
independent genes (Reza et al., 2005b). These results provide the first direct 
evidence that a venom prothrombin activator gene evolved by duplicating a blood 
coagulation factor gene. 
1.5.4 Differences in expression patterns of parallel prothrombin activator 
systems 
Even though TrFX and trocarin D have significant similarities in structure and 
catalytic function, they play distinct physiological roles as mentioned Chapter 
1.5.3. These differences are mainly caused by their distinct expression patterns in 
the following aspects (Reza et al., 2007) (Table 1-3): i) Tissue specificity. As a 
toxin, trocarin D is exclusively expressed in venom gland and exists in an active 
form. TrFX is only expressed in the liver and secreted as a zymogen into the 
plasma. ii) Expression level. By quantitative real-time PCR, it has been shown 
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that the expression level of trocarin D in venom gland is 30 times higher than that 
of TrFX in liver (Reza et al., 2005a). iii) Regulation of expression. The expression 
of trocarin D is inducible, namely its expression is switched on and reaches the 
maximum level when the venom gland is empty and venom needs to be restored, 
while its expression is slowed down or stopped when the venom gland is full 
(Paine et al., 1992; Rotenberg et al., 1971). However, TrFX is constitutively 
expressed in the liver at a steady level (Bahnak et al., 1987; Miao et al., 1992). In 
order to understand the mechanism regulating the different expression patterns of 
trocarin D and TrFX, the complete gene structures including the putative 
promoter regions of these parallel genes have been characterized.  
 
Table 1-3. Comparison of venom and plasma prothrombin activators 
Venom Prothrombin Activator  
(Trocarin D)  
Plasma Prothrombin Activator 
(Tropidechis carinatus FX)  
Function as a toxin to immobilize the prey 
as well as for defense  
Function as haemostatic factors to survive 
vascular injuries  
Exist in active form in the venom gland  Exist as a zymogen in the plasma  
Expressed in the venom gland  Expressed in the liver tissue  
Inducible expression  Constitutive expression  
High-level of expression  Low-level of expression  
 
1.5.5 Comparison of gene structures of trocarin D and TrFX 
The gene organization of trocarin D and TrFX is very similar, namely both genes 
have eight exons and seven introns with identical exon-intron boundaries. Besides 
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the overall gene structure similarities, there are some differences in terms of 
insertion/deletion, between the two genes in the promoter and intron 1 regions 
(Reza et al., 2007).   
In the promoter region, TrFX and trocarin D have very similar cis-elements as 
mammalian FX promoters which have been previously characterized (Reza et al., 
2007). These conserved cis-elements are: i) a CCAAT box (Huang et al., 1992; 
Wilberding and Castellino, 2000), ii) a liver-specific transcription factor HNF-4 
binding site (Hung and High, 1996); iii) a gut-specific GATA-4 (Hung et al., 2001) 
and iv) multiple Sp1/Sp3 binding sites (Hung et al., 2001). Despite these 
similarities, the promoter of trocarin D has a 264 bp insertion compared to TrFX. 
This insertion spans from -297 to -33 bp upstream of the start codon of trocarin D. 
As this insertion does not show similarity to any known sequences in the database, 
bioinformatic software was used to predict the possible transcription factor 
binding sites. Three TATA-like boxes (TLB), a Y-box and a GATA-4 box were 
predicted in this insertion (Fig. 1-2) (Reza et al., 2007). Interestingly, similar 
segment was also found in the promoter region of pseutarin C catalytic subunit 
(PCCS, enzymatic subunit of another venom prothrombin activator similar to FXa) 
from Pseudonaja textilis. These two segments show 95% identity to each other 
(Reza et al., 2007). Therefore, this segment was proposed to be an important 
element for changing expression pattern of trocarin D different from that of TrFX. 
Thus, this insertion was name as VEnom Recruitment/Switch Element (VERSE) 
(Reza et al., 2005b). 
Regarding the introns, trocarin D and TrFX show high similarity in introns 2 to 7 
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(92-99% identity), but have differences in intron 1. Compared to TrFX, the first 
intron of trocarin D has three insertions (214, 1975, and 2174 bp in length) and 
two deletions (255 and 1406 bp). These three insertions showed no significant 
similarity to any known sequences in the NCBI nucleotide non-redundant 
database. Nevertheless, some sequence characteristics were observed. The first 
insertion is nearly an exact repeat (96.33% identity) of the segment spanning from 
3082 to 3299 bp in intron 1 of trocarin D. The other two insertions seem to be 
inverted repeats showing 71% identities to each other (Reza et al., 2007). One 
region in the third insertion shows the sequence characteristics of Scaffold/matrix 
attachment region (S/MAR): i) a long stretch of AT rich sequences (Liebich et al., 
2002); ii) an over-representation of hexanucleotides containing the core motif of 
homeodomain factors (Liebich et al., 2002); iii) enrichment of topoisomerase II 
binding sites (Boulikas, 1996; Liebich et al., 2002); iv) ATTA motifs and AT-rich 
region with H-box (uninterrupted A/T/C at least 25 bp) (Will et al., 1998). 
Interestingly, intron 1 of PCCS also has the similar insertions and deletions 
compared to intron 1 of its homolog (Pseudonaja textilis FX) which is expressed 
in the plasma. The size and location of the PCCS insertions are similar to those of 
trocarin D but differences exist in size and location of those deletions. As S/MAR 
has been known to mediate structural organization of the chromatin and play an 
important role in transcriptional regulation, and similar sequences have been 
identified in PCCS gene as well, these insertions and deletions are probably 
responsible for the differences in expression patterns between trocarin D and 
TrFX (Reza et al., 2005; Reza et al., 2007). 
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1.5.6 VERSE accounts for elevated expression level of trocarin D 
As VERSE was proposed to play an important role in the recruitment of TrFX to 
trocarin D by changing the expression pattern, VERSE was first characterized for 
its up-regulatory activity by luciferase reporter assay in primary snake venom 
gland cells and mammalian cell lines. It was observed that VERSE is able to drive 
the expression of luciferase reporter gene and its up-regulatory effect is 
comparable to the full length trocarin D promoter (Fig. 1-3) (Kwong et al., 2009). 
The previous predicted cis-elements (three TATA-, GATA- and Y-boxes) were 
confirmed to be functional. Besides these predicted cis-elements, three novel cis-
elements (Sup, Up1 and Up2) have been identified by serial deletion studies. Site-
directed mutagenesis studies of these novel cis-elements showed that Up1 and 
Up2 have activating effects, while Sup alone has suppressing effects. In addition 
to this, the transcription start site of trocarin D has been characterized by 5' RACE, 
and the second TATA-like box was shown to be the major TATA box which 
directs the initiation of transcription (Kwong et al., 2009). The above luciferase 
assay results from the primary snake venom gland cells and mammalian cell lines 
(HepG2, HEK293T, CHOK1) were compared. As the results in snake and 
mammalian cells are similar, it suggests that mammalian cell lines could represent 
a good substitute model for primary snake venom gland cells to characterize the 
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Figure 1-2. A) Comparison of Cis-elements in promoter regions of human FX, 
murine FX, TrFX and trocarin D. B) Comparison of intron 1 regions of TrFX 
and trocarin D. The cis-elements in human FX, murine FX, and VERSE were 
verified by experimental data (Huang et al., 1992; Hung and High, 1996; Hung et 
al., 2001; Kwong et al., 2009; Wilberding and Castellino, 2000), while the cis-
elements in TrFX and trocarin D promoter except VERSE were predicted 
according to the sequence similarity (Reza et al., 2007).  
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Figure 1-3. Comparison of up-regulatory activities of promoters of TrFX, 
trocarin D and VERSE. The luciferase reporter activity of VERSE is comparable 
to the full length trocarin D promoter. Trocarin D and VERSE promoters result in 
higher expression level than TrFX. 
1.5.7 Differences in intron 1 region are responsible for tissue-specific 
regulation of trocarin D 
Because VERSE was able to up-regulate gene expression in both venom gland 
cells and mammalian cell lines, the repressor elements which will suppress 
trocarin D expression in non-venom gland cells were hypothesized to locate in 
the differences within first intron of trocarin D. Among all the insertions and 
deletions in intron 1 region of trocarin D, insertion 2 (Ins 2) (1975 bp) was 
capable to repress VERSE promoter activity in three mammalian cell lines (HEK 
293T, CHOK1, HepG2). Further characterization of Ins 2 showed that multiple 
silencing fragments exist in Ins 2.2 (684 bp), which is one subsegment of Ins 2. 
Among the multiple silencing fragments, Ins 2.2.4 (209 bp) was able to silence 
gene expression by almost 100% under both native and heterologous promoters in 
three mammalian cell lines. Hence it is postulated that the most potent silencers 




1.6 Aims and Scope  
Previous research on snake venom evolution proposed that snake venom toxins 
evolved by gene duplication followed by recruitment. This model was proposed 
after an extensive phylogenetic analysis of snake venom toxins and their 
physiological counterparts using the amino acid sequences (Casewell et al., 2012; 
Fry, 2005; Fry and Wüster, 2004; Fry et al., 2003). As described in the previous 
section, after toxin genes evolved by gene duplication, another important change 
of toxin genes is the alteration in expression pattern. In short, snake venom toxins 
are highly expressed in the venom gland when the gland is empty; while 
physiological proteins are constitutively expressed in other tissues at a low level. 
However, some recent studies have shown that some families of snake venom 
toxins co-express in both venom gland and other tissues (Hargreaves et al., 2014; 
Junqueira-de-Azevedo et al., 2014; Vonk et al., 2013), which suggest the 
evolution of venom toxins is dynamic and reversible. To fully understand this 
evolutionary process of venom toxins, the complete gene structures and 
expression patterns of some snake venom toxins and physiological homologs have 
been done (Fujimi et al., 2002a, 2003; Reza et al., 2005b, 2007). The genetic 
differences in regulatory regions between venom toxins and physiological 
proteins are hypothesized to be responsible for altering the expression pattern 
(Fujimi et al., 2003; Reza et al., 2007). However, little study has been performed 
to experimentally confirm the functions of these genetic differences and 
characterize their corresponding transcription factors, which can explain the 
regulatory mechanisms underlying the different expression patterns. Hence this 
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thesis aims to characterize how these genetic differences in the regulatory regions 
contribute to altering the expression pattern of venom toxins during their dynamic 
recruitment from the physiological proteins.  
As trocarin D and its plasma coagulant homolog TrFX has been previously 
characterized in our laboratory, it will be the focus of this thesis. Functionally, 
both trocarin D and TrFX promote blood coagulation by cleaving the same sites 
with same cofactors to convert prothrombin to thrombin. Structurally, they have 
significant similar amino acid sequences and identical domain structures. 
However, they play different physiological roles. As mentioned earlier, we 
proposed that the tissue-specific expression of these two closely related proteins 
contributes to their different physiological roles. 
As VERSE is only responsible for elevated expression level of trocarin D, the 
insertions and deletions in intron 1 region were examined for their roles in 
repressing expression of trocarin D in non-venom gland tissues. Primary studies 
have shown that insertion 2 in intron 1 of trocarin D is able to repress gene 
expression in three mammalian cell lines (HEK293T, HepG2, CHOK1). 
Therefore, this thesis uses trocarin D as a model to characterize the silencing cis-
elements in intron 1 of the gene to understand the regulatory mechanism of tissue- 
and time-specificity of toxin genes.  Specifically, the aims of this thesis are: 
1) To characterize the insertion 2 (1975 bp) of trocarin D intron 1 for its role in 
regulation of tissue- and time-specific gene expression using serial deletion and 
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site-directed mutagenesis luciferase assays in primary snake venom gland cells 
and mammalian cell lines.  
2) To identify the corresponding transcription factors that bind the identified 
silencing cis-elements using proteomics techniques and to study the interaction 
between transcription factors with the cis-elements by biochemical methods.  
In this thesis, we describe the identification of silencing cis-elements using 
luciferase assays and bioinformatics tools. Our data show that a 209 bp region 
within the second insertion is the most potent “silencer”, as it contains two 
silencing elements that work synergistically to suppress TroD expression in 
mammalian cells. Bioinformatics analysis identified five AG-rich motifs in this 
region, and all except the 5th motif were shown to be important for silencing 
function and specific DNA-protein interactions. We also identified specific 
proteins that bind to these motifs and evaluated their roles in gene repression in 
non-venom gland tissues. These findings highlight the importance of AG-rich 
motifs as key regulators of venom gland-specific expression, and suggest the 
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Snake venom toxins are recruited from ancestral physiological proteins through 
gene duplication and dynamic evolution. The duplicated genes acquire mutations 
in both coding and non-coding regions, which confer toxin characteristics. One of 
the important characteristics for toxins is the change in the expression patterns in 
comparison to their ancestral genes. Except for the lectin toxin family in 
Ophiophagus hannah showing 40 times higher expression in the accessory gland 
compared to the venom gland (Vonk et al., 2013), most venom toxins show 
specific and high level expression only in the venom gland. Toxin gene 
expression is induced greatest when the venom gland is empty (Oron and Bdolah, 
1973; Paine et al., 1992; Rotenberg et al., 1971). The tissue-specific expression of  
toxin genes is vital to prevent physiological disorders  in non-venom gland tissues 
(Joseph et al., 1999). This is regulated by the interaction of silencing cis-elements 
and the corresponding transcription factors. Previously, many studies have 
described the role of regulatory cis-elements in genes specifically expressed in 
neuronal and immune cells (Henson et al., 2014; Shimojo and Hersh, 2004). 
However, little information is available on the regulatory mechanism of toxin 
gene expression. Hence, this chapter aims to identify the silencing cis-elements 
and thereby understand the tissue-specific expression of a toxin gene.  
There have been a few studies, which characterized the promoter region of snake 
toxins and evaluated the mechanisms of elevated expression of toxin gene (Fujimi 
et al., 2004; Kwong et al., 2009; Ma et al., 2002). However, the mechanisms of 
negative regulation of toxin genes are poorly understood.  One of the most related 
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work is the identification of a silencer in the promoter region of a -neurotoxin 
gene from Naja sputatrix (Ma et al., 2002). As previously described (Ma et al., 
2001), cardiotoxin and -neurotoxin from Naja sputatrix evolved by gene 
duplication and accelerated evolution. These two proteins are highly similar to 
one another in amino acid and nucleotide sequences, but have different expression 
levels in the venom gland (cardiotoxin: 60% (w/v) of the venom; -neurotoxin: 
3% (w/v) of the venom). Comparison of the complete gene structures for both 
genes revealed a strong silencing cis-element located in the promoter of -
neurotoxin, which lowers the expression level of -neurotoxin in the venom gland 
(Ma et al., 2001; Ma et al., 2002). Even though the presence of silencing cis-
element explains how -neurotoxin and cardiotoxin evolved to have different 
expression levels in the venom gland after gene duplication, it does not address 
the silencing cis-elements which are responsible for venom gland-specific and 
inducible expression for most of the toxins. Therefore, the transcriptional 
regulation of trocarin D and TrFX, which are good examples for parallel toxin 
genes and the physiological homologs, will be interesting to study. The results of 
this study will help us to understand the regulation of tissue- and time- specific 
expression of snake venom toxins.  
As described in Chapter 1, trocarin D and TrFX are homologous genes with 
similar structures and functions but different expression patterns. Comparison of 
the gene structures have revealed that the differences in promoter and intron 1 
regions are probably responsible for regulating the distinct expression patterns. 
Previous study has shown that the insertion VERSE in the promoter of trocarin D 
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accounts for its high level expression in comparison to TrFX (Kwong et al., 2009). 
VERSE does not regulate tissue-specific expression of trocarin D. Hence the 
differences in intron 1 region of trocarin D was characterized for their silencing 
functions in non-venom gland tissues.  
Based on the preliminary results (Shiyang, 2010), one insertion fragment 
(insertion 2, Ins 2, 1975 bp) in the first intron of trocarin D reduced VERSE 
promoter activity significantly in three non-venom gland cell lines HEK293T, 
CHOK1 and HepG2 (Fig. 2-1). In Ins 2, there are multiple silencing fragments 
located in one region Ins 2.2. Among them, Ins 2.2.4 (209 bp) accounts for most 
of the silencing effect of Ins 2 (Fig.2-2). As Ins 2.2.4 does not show any 
significant similarity with any known sequence in the database, and the silencing 
cis-elements are relatively small in terms of the size (~10 bp), the investigation 
was conducted to identify exact sequences which potentially could be silencing 
cis-elements.  
Therefore, this chapter aims to identify the silencing cis-elements within Ins 2.2.4 
by serial deletion and site-directed mutagenesis using luciferase reporter gene 
assay in both unmilked primary venom gland cells (the toxins do not express in 
unmilked venom gland cells) and mammalian cell lines. Through this study, 
different AG-rich motifs were identified and it was proven that the synergism 
between two AG-rich motifs is essential for silencing function. Finally, this 
identified essential silencer structure was also observed in other snake toxin genes. 
This is the first study of molecular details of silencing cis-elements involved in 
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Figure 2-1. A) Comparison of intron 1 of TrFX and trocarin D. White 
rectangles represent the insertions in the intron1 of trocarin D compared to TrFX. 
Green rectangles represent the deletions in intron 1 of trocarin D. B) 
Characterization of repressive effect of insertions/deletions present in 
trocarin D intron 1. The light grey boxes represent the VERSE promoter, the 
black boxes represent the five nucleotides overlapping the intron/exon boundary 
of TroD intron 1, and shaded rectangles represent the insertion and deletion 
segments from TroD intron 1. Firefly luciferase genes under the control of VERSE 
promoter and insertion/deletion segments were co-transfected with Renilla 
luciferase reporter vector as an internal control into CHOK1, HepG2, HEK293T 
cell lines. The relative luciferase activities were calculated through dividing the 
firefly luciferase activity by Renilla luciferase activity. The results are represented 
as relative percentage to that of VERSE promoter which was taken as 100%. Each 
data point is the mean ± S.E. of at least three experiments, each done in triplicate 




2.2 Materials and Methods 
2.2.1 Construct of recombinant vectors 
2.2.1.1 Design of the construct 
The trocarin D intron 1 insertion 2.2.4 fragment (209 bp) is further divided into 
three different sub-segments with similar size (60-100 bp), namely Ins 2.2.4.1, Ins 
2.2.4.2 and Ins 2.2.4.3. Following the previous methods (Kwong et al., 2009), five 
nucleotides straddling the intron/exon boundaries of 5’ and 3’ end of the trocarin 
D intron 1 was included in each sub-segment. Each sub-segment has 15 
nucleotides overlapping with the adjacent fragment for primer design.  
2.2.1.2 Cloning of the construct 
To investigate the gene regulatory effect of these three sub-segments of intron 1, 
the amplified segments were ligated behind VERSE promoter using SacI site. 
These constructs were directly cloned into the promoter-less pGL4.10 vector 
containing the firefly luciferase reporter gene between KpnI and NheI sites. The 
resulting constructs are termed VIns 2.2.4.1, VIns 2.2.4.2, and VIns 2.2.4.3, 
respectively. To evaluate whether this silencer is promoter dependent, the Ins 
2.2.4 sub-segments were also ligated behind a heterogeneous cytomegalovirus 
(CMV) promoter using HindIII site and cloned into promoter-less pGL4.10 vector 
in the same way. The resulting constructs are termed CMVIns 2.2.4.1, CMVIns 
2.2.4.2, and CMVIns 2.2.4.3, respectively.  
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All constructs were verified by DNA sequencing using ABI PRISM® BigDye® 
terminator cycle sequencing ready reaction kit (Perkin Elmer, Foster City, CA, 
USA) according to the manufacturer’s instructions.  
2.2.2 Bioinformatics analysis of the AG-rich motifs 
2.2.2.1 Identification of AG-rich motifs in Ins 2.2.4 
Sequence of Ins2.2.4 was analyzed by Multiple Em for Motif Elicitation (MEME) 
using the default settings to discover repeat sequences with similarities and a 
motif matrix was identified (Bailey et al., 2009).  
 2.2.2.2 Identification of similar AG-rich motifs in intron 1 of other snake genes 
The identified AG-rich motif matrix was scanned against other snake genes using 
Find Individual Motif Occurrences (FIMO). Only sequences with significant 
similarity (p-value <1×10-5 and q-value <0.1) were evaluated (Bailey and 
Gribskov, 1998).  
2.2.3 Design of mutation sequences 
Mutation of motifs in Ins 2.2.4.1 
Motif 1 mutation: 
GGAAAAGCTCTCTCCGAATTTAAGATTTAAAAAAACCACCAAGAAAGGGAAAAA
TAAG  





Mutation of motifs in Ins 2.2.4.2 
Motif 3 mutation 
GAAAGGGAAAAATAAGGTGAAAAATCGATACAATGTCAGAAAACAACAGAAAAG
AGGAATACAACAGCTCATATCGACTAAGAGGGTGGAGATTAAGAG 
Motif 4 mutation 
GAAAGGGAAAAATAAGGTGAAAAATCGATACAATGTCAGAAAACAACAGAAAAG
AGGAATACAACAGAGAGGGGAGACTAAGCTATCTTCGATTAAGAG  
Motif 3_4 mutation 
GAAAGGGAAAAATAAGGTGAAAAATCGATACAATGTCAGAAAACAACAGAAAAG
AGGAATACAACAGCTCATATCGACTAAGCTATCTTCGATTAAGAG 
2.2.4 Cell culture 
2.2.4.1 Culture of mammalian cell lines 
CHOK1, HepG2 and HEK293T cell lines were maintained in DMEM media 
supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. All 
mammalian cell lines were incubated at 37℃ in a humidified atmosphere 
containing 5% CO2. 
2.2.4.2 Culture of primary venom gland  
Venom glands of P. textilis (common brown snake) were dissected from the snake 
and gland epithelial cells were isolated by a fine cell strainer (Kwong et al., 2009). 
The cell suspension was washed with medium A (DMEM, 100 U/ml penicillin, 
100 μg/ml streptomycin antibiotics and 0.25 μg/ml amphotericin B antimycotics) 
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three times. The washed cells were suspended in medium B without antibiotics 
(DMEM complemented with 3% fetal bovine serum, 10 μg/ml insulin, 5 μg/ml 
transferrin, 0.07 μg/ml sodium selenite, 10 μg/ml dexamethasone, 80 ng/ml 
epidermal growth factor, 0.1 μM retinoic acetate). The cell suspension was seeded 
into collagen coated culture plates and incubated at 30℃ in a humidified 
atmosphere containing 5% CO2.  
2.2.5 Transfection of mammalian cell lines and primary venom gland cells 
Cells were seeded into collagen coated 48-well plate at a density of 2 × 104 cells 
per well. As the primary venom gland cells are highly adherent to one another, 
cells were immediately transfected after seeding to increase the transfection 
efficiency. For the mammalian cells, cells were grown to 70% before transfection. 
For all the cell types, the transfection efficacy was normalized by co-transfecting 
300 ng of insert-pGL4.10 firefly luciferase reporter construct with 10 ng of 
pGL4.73 vector containing the Renilla luciferase gene which is regulated by a 
SV40 promoter. At the same time, cells seeded in the transparent plate were 
transfected with eGFP vector. Cells were transfected using lipofectamine 2000 
(Invitrogen, Carlsbad, CA, USA) at the weight ratio 1/2 (vector/lipofectamine 
2000) according to the manufacturer’s instructions. After 24 h, transfection 
efficacy was first visualized by the transfected eGFP vector.  
2.2.6 Luciferase assay  
Luciferase activity was measured using the Dual-GloTM Luciferase Assay System 
(Promega, Madison, WI, USA) according to the manufacturer’s instructions in a 
plate reader (infinite M200 pro, TECAN, Männedorf, Switzerland). Relative light 
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units were calculated by dividing the firefly luciferase signals by the normalizing 
Renilla luciferase signals. Luciferase assays for all the constructed luciferase 
reporter vectors were all performed in triplicate and the assays were repeated at 
least three independent times in the three mammalian cell lines. Due to scanty 
availability, the luciferase activities from the primary venom gland cells are the 
mean of one or two experiments carried out in triplicates. The relative luciferase 
activity mean and standard error of each construct were calculated and 
represented as relative to that of VERSE promoter or CMV enhancer/promoter 
which was taken as 100%. 
2.3 Results 
2.3.1 Multiple silencing fragments in Ins 2.2.4 of trocarin D intron 1 function 
synergistically to repress VERSE promoter activity in mammalian cell lines. 
Previous study by Shiyang Kwong showed that trocarin D intron 1 Ins 2 represses 
VERSE promoter activity and gene expression, and the 209 bp fragment Ins 2.2.4 
was the strongest repressive fragment, which  reduced the reporter gene 
expression level to 0.8-1.3% in HEK293T, CHOK1 and HepG2 cell lines (Kwong, 
2010).  
To pinpoint the location of the essential repressive cis-elements, Ins 2.2.4 was 
further divided to three sub-segments with similar length and then concatenated to 
3’end of the VERSE promoter (Fig. 2-1). These VERSE-insertion fragments were 
then used to drive the expression of the firefly luciferase gene as a reporter in 
non-venom gland tissues. Since there are no stable snake cell lines available and 
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due to limited access of primary snake cells, three mammalian cell lines 
HEK293T, CHOK1 and HepG2 were used. As shown earlier (Kwong et al., 2009), 
VERSE showed similar up-regulatory effect in these cell lines as the primary cells 
from snake venom glands. Only a significant reduction in luciferase activities by 
VERSE-insertion promoter constructs compared to VERSE promoter construct 
was considered as the silencing effect. VIns 2.2.4.1 and VIns 2.2.4.2 showed 
reducedluciferase activity of 7.19%-12.43% and 6.41%-12.07% in all three 
mammalian cell lines, respectively (Fig. 2-2). VIns 2.2.4.3 did not show any 
significant silencing effect in HepG2 cell line, and reduced only VERSE promoter 
activity to 59.4%-70% in HEK293T and CHOK1 cell lines. Full length VIns 2.2.4 
reduced luciferase expression better than both VIns 2.2.4.1 and VIns 2.2.4.2 (Fig. 
2-2). This suggests that there are multiple silencing cis-elements present in Ins 
2.2.4, acting synergistically to silence gene expression. Thus, Ins 2.2.4 is the 


































Figure 2-2. Characterization of repressive effect of subsegments in Ins 2.2.4. 
The light grey boxes represent the VERSE promoter, the black boxes represent the 
five nucleotides overlapping the intron/exon boundary of TroD intron 1, and 
shaded rectangles represent the insertion segments from TroD intron 1. Firefly 
luciferase genes under the control of VERSE promoter and insertion/deletion 
segments were co-transfected with Renilla luciferase reporter vector as an internal 
control into CHOK1, HepG2, HEK293T cell lines. The relative luciferase 
activities were calculated through dividing the firefly luciferase activity by 
Renilla luciferase activity. The results are represented as relative percentage to 
that of VERSE promoter which was taken as 100%. Each data point is the mean ± 
S.E. of at least three experiments, each done in triplicate.  
 
2.3.2 Ins 2.2.4 represses gene expression in unmilked snake venom gland cells 
As the unmilked venom gland cells have low venom expression activity, the 
primary venom gland cells from P. textilis was used to evaluate the most potent 
silencer Ins 2.2.4 and its subsegments Ins 2.2.4.1 and Ins 2.2.4.2. Since the 
availability of T. carinatus is limited, venom glands from P. textilis were chosen 
for the experiment, as we did previously (Kwong et al., 2009). The gene encoding 
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Pseutarin C catalytic subunit from P. textilis is similar to TroD; particularly it has 
highly identical VERSE (97.34%) and Ins 2.2.4 (93.75%) (Figure 2-3). The results 
of the luciferase expression in the P. textilis venom gland cells were similar to 
that using the mammalian cell lines (Fig.2-4). This indicates that HepG2, 
HEK293T and CHOK1 mammalian cell lines are reasonable substitutes for 
unmilked venom gland cells to characterize silencing fragments, and the 
transcriptional factors which bind to the silencing fragments should be conserved 
between mammalian cells and snake cells. 
2.3.3 Identification of silencing motifs in Ins 2.2.4. 
Since Ins 2.2.4 is the smallest region containing the most potent silencing cis-
elements, it is a good model for identifying the sequence characteristics which are 
responsible for transcriptional repression. A systematic and careful analysis of the 
sequence revealed that the Ins 2.2.4 contains multiple similar AG-rich sequences 
(Fig. 2-5). Further analysis showed that other silencing segments identified in Ins 
2 fragment also contain similar AG-rich sequences. Similar AG-rich sequences 
are found in tandem in multiple silencing cis-elements and known to repress gene 
expression (Déjardin et al., 2005; Sipos et al., 2007).  Therefore, we hypothesized 
that these motifs enable silencing function. Ins 2.2.4 sequence was screened using 
the motif finding algorithm MEME (Bailey et al., 2009). A 12-bp AG-rich motif 
were found at five different positions within this region (Fig. 2-5). According to 
the positions, these sequences are named as motif 1 to 5 respectively. Motifs 1, 3 
and 4 have similar sequences AGAG(A\G)(G\A)(T\G)GGAGA, which are named 
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as class A motifs, while motifs 2 and 5 are more similar to each other with a 
sequence A(A/G)AAAGGGAA(G/A)A, and they are termed as class B motifs. 
A
B
TroD    TGTAGTGTACTTGTTTGCATACTCGTAATACTGCATTCCTATTGGACAGATACCATCGCT 60 
PCCS    TGTAGTGTACTTGTTTGCATACTCATAATACTGCATTCCTATTGGACAGATACTATCGCT 60 
        ************************ **************************** ****** 
 
TroD    TAACGATTGGTAGATAACAACAGTTCTAATTGGCCGCCTAAGCGATGGGAGTTTTAAATA 120 
PCCS    TAACGATTGGTAGATAACAACAGTTCTAATTGGACGCCTAAGCAGTGGGAGTTTTAAATA 120 
        ********************************* *********  *************** 
 
TroD    AATGCCATTGGTTGCGAGCCGCGAGCAGCCGCTATAAAAGGGGCTGCCGCGGCTCGACTT 180 
PCCS    AATGCCATTGGTTGCGAGCCGCGAGCAGCCGCTATAAAAGGGACTGCCGCGGCTCGACTT 180 
        ****************************************** ***************** 
 
TroD    TAGTTGAAGTTACTGACAGTTAATAAAGAGCTGAATTCAACTCCGGTCTCGAGTCTGCTT 240 
PCCS    TAGTTGAAGTTACTGACAGTTAATAAAGAGCTGAATTCAACTCCGGTCTCGAGTCTGCTT 240 
        ************************************************************ 
   
TroD    TTGTTCTGGCGACAGAACAAGAAC 264 
PCCS    T-GTTCTGGCGATAGAACAAGAAC 263 
        * ********** *********** 
TroD     GGAAAAGAGAATGGAGAATTTAAGATTTAAAAAAACCACCAAGAAAGGGAAAAATAAGGT 60 
PCCS     GG-AAAGAGAATGGAGAATTTAAAATTTAAAAAAACAACCAAGAAAGGGAAAAATAAGGT 59 
         ** ******************** ************ *********************** 
 
TroD     GAAAAATCGATACAATGTCAGAAAACAACAGAAAAGAGGAATACAACAGAGAGGGGAGAC 120 
PCCS     GAAAAATCAATACAACGTCAGAAAACAACAGAAAAGAGGAATACAACAGAGAGGGGAGAC 119 
         ******** ****** ******************************************** 
 
TroD     TAAGAGGGTGGAGATTAAGAGATAGAGGGGTAAAAAGGCTAGATTTGACAAGAAAGGAAG 180 
PCCS     TAAAAGGGGGGAGATTAAGAGATAGGGGGGTAAAAAGGCTAGCTCTGACAAGAAATGAAG 179 
         *** **** **************** **************** * ********** **** 
 
TroD     GGAAAAAGGGAAGATAAGTTATAAAGGCT 209 
PCCS     AGAAAAAGGGAAGAGAAGTTATAAAGGCT 208 
         ************* ************** 
 
Figure 2-3. Similarity of VERSE and Ins 2.2.4 between TroD and PCCS. A) 
Alignment of VERSE from TroD and PCCS promoter by ClustalW.  B) 
Alignment of Ins2.2.4 from TroD and PCCS  intron1 by ClustalW. * indicates the 





















Figure 2-4. Comparison of repressive effect of Ins 2.2.4 and its subsegments 
in mammalian cell lines and primary unmilked snake venom gland cells. The 
light grey boxes represent the VERSE promoter, the black boxes represent the five 
nucleotides overlapping the intron/exon boundary of TroD intron 1, and shaded 
rectangles represent the insertion segments from TroD intron 1. Firefly luciferase 
genes under the control of VERSE promoter and insertion/deletion segments were 
co-transfected with Renilla luciferase reporter vector as an internal control into 
CHOK1, HepG2, HEK293T cell lines and unmilked primary P. textilis venom 
gland cells. The relative luciferase activities were calculated through dividing the 
firefly luciferase activity by Renilla luciferase activity. The results are represented 
as relative percentage to that of VERSE promoter which was taken as 100%. Each 
data point is the mean ± S.E. of at least three experiments, each done in triplicate. 
The results from the primary venom gland cells are the mean of one experiment 






















Figure 2-5. Identification of AG-rich motifs in Ins 2.2.4 in trocarin D intron 1. 
The upper panel is the “position-specific scoring matrix” of identified AG-rich 
motifs. Five AG-rich motifs were identified in Ins2.2.4 (motifs 1-5). Based on the 
sequence similarity, motifs 1, 3 and 4 were classified as class A (red hexagons), 
while motifs 2 and 5 were classified as class B motifs (green hexagons). 
 
2.3.4 Synergism between two silencing motifs is essential to repress gene 
expression  
As figure 2-6 shows, all three Ins 2.2.4 sub-segments previously constructed 
contain at least two or more AG-rich motifs. In order to characterize whether a 
single motif is able to silence the gene expression, constructs containing 
individual motifs were evaluated. Since motifs 3 and 4 are adjacent to each other 
(the interval is 3 bp), constructs were designed to contain only motif 4 (VIns 
2.2.4C) or motif 3 and 4 together (VIns 2.2.4D). Motif 1 (VIns 2.2.4A) repressed 
VERSE promoter activity by 58-67% in mammalian cell lines, but other individual 
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motifs repressed <25% and sometimes enhanced the expression (Fig. 2-7). The 
silencing potency of single motif was less compared to constructs containing two 
or more motifs (Fig. 2-6 and Fig. 2-7). These results suggest that synergism 
between two complete motifs is essential for silencing. Interestingly, construct 
VIns 2.2.4D containing adjacent motifs 3 and 4 significantly enhanced the 
expression (Fig. 2-7). It is not clear whether longer spacer between two motifs or 
the sequence composition is important for silencing. Addition of motif 2 or motif 
5 to motifs 3 and 4 repress gene expression, hence the synergism between motif 2 
or 5 and motif 3_4 is important for silencing. As the repression by VIns 2.2.4.3 
(motifs 3, 4 and 5) was less than VIns 2.2.4.2 (motifs 2, 3 and 4), suggesting that 
motif 5 has less silencing effect compared to motif 2. Further, we changed motif 5 
to motif 2 in VIns 2.2.4.3, and the silencing effect of this construct is much 
stronger than VIns 2.2.4.3 (Fig. 2-6) indicating that motif 2 has a better silencer 
effect compared to motif 5. 
To further evaluate the synergism between two motifs is essential for silencing, 
site-directed mutations were made to the central eight nucleotides of motifs 1-4 
individually within the silencing fragments VIns 2.2.4.1 and VIns 2.2.4.2. 
Mutations of motifs 1 and 2 in Ins 2.2.4.1 almost completely abrogated its 
silencing function (for VIns 2.2.4.1 mut1, the relative luciferase activity is 90-
113%; for VIns 2.2.4.1 mut2, the relative luciferase activity is 72-75%). Similarly, 
mutations of motifs 3 and 4 in Ins 2.2.4.2 individually disrupted the silencing 
function significantly (the relative luciferase activity for VIns 2.2.4.2 mut3 is 18-
19%; for VIns 2.2.4.2 mut4 is 23-25%). Interestingly, mutation of motifs 3 and 4 
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individually in Ins 2.2.4.2 did not fully disrupt the silencing function of Ins 
2.2.4.2. This was probably due to the fact that there are still two complete motifs 
present in the single mutation constructs, which cause the silencing effect. Hence, 
double mutation of motif 3 and 4 was done in Ins 2.2.4.2. However, the double 
mutation construct did not further rescind the silencing function, suggesting the 
importance of motif 2 (Fig. 2-8).  
 



















Figure 2-6. Location of identified AG-rich motifs in silencing subsegments of 
Ins 2.2.4. The light grey rectangles represent the VERSE promoter, the black 
blocks represent the five nucleotides overlapping the intron/exon boundary of 
trocarin D intron 1, shaded rectangles represent the insertion segments in intron 1 

























Figure 2-7. Characterization of repressive effect of segments containing 
single AG-rich motif. The light grey rectangles represent the VERSE promoter, 
the black blocks represent the five nucleotides overlapping the intron/exon 
boundary of trocarin D intron 1, shaded rectangles represent the insertion 
segments in intron 1 of trocarin D. Red and green hexagons represent class A and 
B AG-rich motifs. Firefly luciferase genes under the control of VERSE promoter 
and respective insertion segments were co-transfected with Renilla luciferase 
reporter vector as an internal control into HepG2, HEK293T and CHOK1 cell 
lines. The results are represented as relative percentage to that of VERSE 
promoter which was taken as 100%. Each data point is the mean ± S.E. of at least 


































Figure 2-8. Characterization of the repressive effect based on the synergism 
between two AG-rich motifs. The grey rectangles represent the VERSE promoter, 
the black blocks represent the five nucleotides overlapping the intron/exon 
boundary of trocarin D intron 1, shaded rectangles represent the insertion 
segments in intron 1 of trocarin D. Red and green hexagons represent class A and 
B AG-rich motifs. Blue and yellow hexagons represent mutation of the 
corresponding AG-rich motif. Firefly luciferase genes under the control of VERSE 
promoter and respective insertion segments were co-transfected with Renilla 
luciferase reporter vector as an internal control into HepG2, HEK293T and 
CHOK1 cell lines. The results are represented as relative percentage to that of 
VERSE promoter which was taken as 100%. Each data point is the mean ± S.E. of 
at least three experiments, each done in triplicate. * indicates P<0.05 (one-sided t 
test), ** indicates P<0.02 (one-sided t test), *** indicates p<0.005 (one-sided t 
test).  
 
2.3.5 Ins 2.2.4 silences heterologous Cytomegalovirus (CMV) promoter 
A common feature of many silencing cis-elements is their ability to inhibit 
transcription driven by heterologous promoters (Ogbourne and Antalis 1998). We 
individually concatenated silencing functional fragment Ins 2.2.4, Ins 2.2.4.1 and 
Ins 2.2.4.2 behind a heterologous CMV promoter. Similar to the VERSE-insertion 
constructs, all CMVIns 2.2.4, CMVIns 2.2.4.1 and CMVIns 2.2.4.2 constructs had 
lower luciferase activity compared to the CMV promoter (Fig. 2-9). CMVIns 2.2.4 
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showed stronger silencing effect compared to CMVIns 2.2.4.1 and CMVIns 
2.2.4.2 (Fig. 2-9). This confirms that the multiple silencing cis-elements in Ins 
2.2.4.1 and Ins 2.2.4.2 function synergistically to silence gene expression. 
However, the effects of Ins 2.2.4, Ins2.2.4.1 and Ins 2.2.4.2 on homogenous 
VERSE promoter were slightly stronger compared to that on heterologous CMV 
promoter. This may be caused by different cis-elements in the core sequence of 
VERSE and CMV promoter, and CMV promoter has more potent activating effect 
compared to VERSE promoter in the mammalian cell lines (Kwong et al., 2009). 















Figure 2-9. Characterization of repressive effect of sub-segments in Ins 2.2.4 
on CMV promoter. The light brown rectangles represent the CMV promoter, the 
black blocks represent the five nucleotides overlapping the intron/exon boundary 
of trocarin D intron 1, shaded rectangles represent the insertion segments in 
intron 1 of trocarin D. Firefly luciferase genes under the control of respective 
promoters and insertion segments were co-transfected with Renilla luciferase 
reporter vector as an internal control into HepG2, HEK293T and CHOK1 cell 
lines. The results are represented as relative percentage to that of CMV promoter 
which was taken as 100%. Each data point is the mean ± S.E. of at least three 
experiments, each done in triplicate. 
75 
 
2.3.6 Bioinformatic analysis of silencing motifs in other snake toxin and their 
physiological counterpart genes 
Prothrombin activator genes: As described above, we identified five AG-rich 
motifs in Ins 2.2.4 region of TroD gene. In addition, another 12 AG-rich motifs 
were also found in its intron 1 on both strands. All these 17 AG-rich motifs are 
within the insertions of TroD (Fig. 2-10A and Table 2-1). Ins 2 has nine motifs in 
the coding strand arranged in two clusters; seven motifs (four class A and three 
class B motifs) are separated by 0 to 54 bp (two in Ins 2.2.3 and five in Ins 2.2.4) 
and two motifs (one each of class A and B motifs) are next to each other in Ins 
2.3. Ins 3 (invert repeat of Ins 2) has eight motifs in the non-coding strand; seven 
of these are in clusters of two (one each of class A and B motifs) and five (two 
class A and three class B motifs) motifs (Fig. 2-10A and Table 2-1). The eighth 
motif belongs to class A. Ins 2 has much stronger silencing potency compared to 
Ins 3 (Fig. 2-1). It is not clear whether the number, distribution, organization or 
the orientation of class A and class B motifs are important for the silencing 
function. Overall, group D vPAs appear to have significant number of AG-rich 
motifs in their intron 1 compared to its physiological counterpart, TrFX gene. 
The catalytic subunit of pseutarin C (group C vPA), PCCS, and its physiological 
homolog PFX1 have also evolved through gene duplication (Reza et al., 2006). 
Similar to TroD, a highly similar VERSE insertion was found in the promoter 
region of PCCS. However, this insertion is 11 bp upstream compared with that in 
TroD and thus, the origins of group C and D vPAs are most likely independent 
events (Reza et al., 2007). PCCS intron 1 also has three insertions and two 
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deletions compared to PFX1. The sites and sizes of the insertions are similar 
compared to those in TroD intron 1 (Fig. 2-10B), but the sizes of deletions are 
distinct (5305 bp and 544 bp in PCCS compared to 338 bp and 1406 bp in TroD) 
further supporting independent evolution of these two groups of vPAs. Nine AG-
rich motifs were found on the coding strand in Ins 2 of PCCS. Seven of them are 
clustered in the same order and organization similar to TroD; except for motif 4, 
which has two nucleotide changes, all other motifs are identical (Fig. 2-10B and 
Table 2-1). There is one class A (895 bp upstream) and one class B (563 bp 
downstream) motifs separated from this cluster. Similar to TroD, seven identical 
motifs are present in Ins 3 region on the non-coding strand except one is missing 
in PCCS. However, minor variations in the spacing (3-8 bp) between these motifs 
are found within this cluster. In total, there are five class A motifs and four class 
B motifs on the coding strand in Ins 2, while three class A motifs and four class B 
motifs on the non-coding strand in Ins 3. We also found a class B AG-rich motif 
in Del 1. PCCS has 16 AG-rich motifs in Ins 2 and Ins 3 compared to PFX1. As 
PCCS is exclusively expressed in venom gland (Reza et al., 2006), these AG-rich 
motifs may be responsible for silencing PCCS in non-venom gland tissues.  
Phospholipase A2 genes:  
To evaluate the relationship between pancreatic and venom PLA2 genes, Tamiya 
and his collaborators analyzed the several gene sequences encoding PLA2 from 
Laticauda semifasciata (Fujimi et al., 2002a, 2002b). Group IA PLA2 gene is 
expressed 100-300 times higher in the venom gland compared to pancreas, while 
group IB'' PLA2 gene is expressed at similar low levels in both venom gland and 
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pancreas. They found insertions of 411 bp, 1250 bp (AG-rich sequence) and 174 
bp (consisted of repetitive units) in the promoter, the first and second introns, 
respectively, of group IA PLA2 gene compared to group IB'' PLA2 gene (Fujimi et 
al., 2002a, 2004). The promoter insert enhances the expression of the reporter 
gene in CHO cell line by 7-fold (Fujimi et al., 2004), but the roles of other inserts 
are not clear. The gene sequences for group IA and group IB'' PLA2s are 87.7% 
similar and the absence of pro-peptides in them indicates that they arose from a 
common prototype of group IA, an evolutionary intermediate evolved from the 
ancestral pancreatic PLA2 gene (Fujimi et al., 2002a).  
Fujimi et al. identified 11 inserts in the first intron of group IA PLA2 gene 
compared to group IB'' PLA2 gene (Fujimi et al., 2002a). 10 out of 11 inserts form 
one big cluster of 21 AG-rich motifs in group IA PLA2 gene, while two small 
clusters of two AG-rich motifs in group IB'' PLA2 genes (Fig. 2-10C and Table 2-
2). All these motifs are similar to motif 3 (class A) with one or two nucleotide 
differences. In addition, there is another motif (class B) in the non-coding strand 
in intron 2 of group IA gene. As the 411-bp insert in the promoter region of group 
IA PLA2 (venom) gene does not regulate its venom gland-specific expression 
(Fujimi et al., 2004), these AG-rich motifs may be responsible for reducing its 
expression in non-venom gland tissues.  
Metalloproteinase genes: Ophiophagus hannah has three genes encoding 
metalloproteinases with distinct expression patterns (Vonk et al., 2013). One gene 
(S3444 gene 2) has ~300-fold higher expression in the venom gland compared to 
accessory gland, while the other two genes have 2.5-6 fold higher expression in 
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accessory gland and/or pooled tissues compared to venom gland. We found four 
AG-rich motifs in the venom gland-specific gene. However, these motifs are not 
clustered. One motif each in introns 3 (class A) and 4 (class B) are separated by 
2445 bp and the other two motifs (class A) in intron 14 are separated by 2659 bp 
(Table 2-3). Other two genes have zero and one AG-rich motif (class B, intron 9).  
Housekeeping genes in Ophiophagus hannah: We also searched the AG-rich 
motif matrix against five housekeeping genes. We have choose genes involved in 
different aspects of cellular activities including respiration (SDHA), glycolysis 
(GAPDH), transcription (TBP), translation (RPL13A) and cell mechanics 
(ACTG1). They have relatively stable expression at different levels in various 
tissues. Although some of these genes reached 45 kbp, only SDHA gene has one 
AG-rich motif (class B) (Table 2-3).  
Overall, venom gland-specific genes appear to have higher number of AG-rich 
motifs compared housekeeping (or non-venom gland-specific) genes (Table 2-4). 
Further sequence analyses and concurrent experimental evaluation is essential to 
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Figure 2-10. AG-rich motifs in genes of toxins and their physiological 
counterparts. AG-rich motifs in intron 1 of TroD and TrFX (A), PCCS and 
PFX1 (B) and LsPLA2GL1-1 and LsPLA2GL16-1 (C). White boxes represent the 
intron 1 regions. Yellow boxes represent the insertions in TroD, PCCS and 
LsPLA2GL1-1 compared to TrFX, PFX and LsPLA2GL16-1, respectively. Blue 
boxes represent the deletions in toxin genes compared to their cognate genes. Red 





Table 2-1. Sequence and location of AG-rich motifs in snake prothrombin activator genes 
Species Gene (bp) Expression pattern



















AGAAAAGGGAAA 2601 2612 + intron 1 4.36E-06 0.0166
0 AAAGAGGGGAAA 2610 2621 + intron 1 2.80E-06 0.0123
0 AGAGAATGGAGA 2622 2633 + intron 1 1.47E-06 0.0104
24 AGAAAGGGAAAA 2658 2669 + intron 1 2.52E-06 0.012
54 AGAGAGGGGAGA 2724 2735 + intron 1 4.62E-08 0.00263
3 AGAGGGTGGAGA 2739 2750 + intron 1 7.66E-07 0.00873
48 AAAAAGGGAAGA 2799 2810 + intron 1 2.52E-06 0.012
489 AGAGAGTGAAAA 3300 3311 + intron 1 2.52E-06 0.012
0 AAAGAGGGGAGA 3309 3320 + intron 1 6.27E-07 0.00873
816 AAAGAGGGGAGA 4137 4148 - intron 1 6.27E-07 0.00873
0 AGAGAGTGAAAA 4146 4157 - intron 1 2.52E-06 0.012
764 AGAAGAGGGAAA 4922 4933 - intron 1 7.06E-06 0.0237
52 AAAAAGGGAAAA 4986 4997 - intron 1 6.06E-06 0.0216
24 AGAGAATGGAGA 5022 5033 - intron 1 1.47E-06 0.0104
9 AGAAAGGGGAAA 5043 5054 - intron 1 1.47E-06 0.0104
314 AGAAAGTGAAAA 5369 5380 - intron 1 3.61E-06 0.0147
570 AGATAGGGGAGA 5951 5962 - intron 1 7.69E-06 0.0244







AGAGAGGGGAGA 2288 2299 + intron 1 4.62E-08 0.000918
895 AGAAAAGGGAAA 3195 3206 + intron 1 4.36E-06 0.0124
0 AAAGAGGGGAAA 3204 3215 +  intron 1 2.80E-06 0.00927
0 AGAGAATGGAGA 3215 3226 + intron 1 1.47E-06 0.00832
24 AGAAAGGGAAAA 3251 3262 + intron 1 2.52E-06 0.00912
54 AGAGAGGGGAGA 3317 3328 + intron 1 4.62E-08 0.000918
3 AAAGGGGGGAGA 3332 3343 + intron 1 1.77E-06 0.00881
48 AAAAAGGGAAGA 3392 3403 + intron 1 2.52E-06 0.00912
491 AGAGAGTGAAAA 3895 3906 + intron 1 2.52E-06 0.00912
820 AAAGAGGGGAGA 4727 4738 - intron 1 6.27E-07 0.00831
778 AGAAGAGGGAAA 5517 5528 - intron 1 7.06E-06 0.0176
52 AAAAAGGGAAAA 5581 5592 - intron 1 6.06E-06 0.0161
24 AGAGAATGGAGA 5617 5628 - intron 1 1.47E-06 0.00832
10 AGAAAGGGGAAA 5639 5650 - intron 1 1.47E-06 0.00832
318 AGAAAGTGAAAA 5969 5980 - intron 1 3.61E-06 0.011
563 AGATAGGGGAGA 6544 6555 - intron 1 7.69E-06 0.018




Table 2-2. Sequence and location of AG-rich motifs in snake phospholipase A2 genes 
Species Gene (bp) Expression pattern 



















AGAGAGGAGAGA 994 1005 + intron 1 8.93E-06 0.00524
96 AGAGAGAGGAGA 1102 1113 + intron 1 6.45E-06 0.00524
0 AGAAAGAGGAGA 1111 1122 + intron 1 9.17E-06 0.00524
82 AGAGAGGAGAGA 1205 1216 + intron 1 9.30E-07 0.00524
85 AGAGAGAGGAGA 1302 1313 + intron 1 6.45E-06 0.00524
90 AGAGAGGAGAGA 1404 1415 + intron 1 8.93E-06 0.00524
3 AGAAAGAGGAGA 1419 1430 + intron 1 9.17E-06 0.00524
30 AGAGAGAGGAGA 1461 1472 + intron 1 6.45E-06 0.00524
43 AGAGAGAGGAGA 1516 1527 + intron 1 6.45E-06 0.00524
0 AGAAAGGGGAGA 1525 1536 + intron 1 2.15E-07 0.00524
30 AGAAAGAGGAGA 1567 1578 + intron 1 9.17E-06 0.00111
85 AGAGAGAGGAGA 1664 1675 + intron 1 6.45E-06 0.00524
0 AGAAAGGGGAGA 1673 1684 + intron 1 2.15E-07 0.00111
32 AGAGAGGAGAGA 1717 1728 + intron 1 8.93E-06 0.00111
1 AGAGAGGAGAGA 1730 1741 + intron 1 8.93E-06 0.00524
3 AGAAAGAGGAGA 1745 1756 + intron 1 9.17E-06 0.00524
83 AGAGAGAGGAGA 1840 1851 + intron 1 6.45E-06 0.00524
0 AGAAAGAGGAGA 1849 1860 + intron 1 9.17E-06 0.00524
91 AGAGAGAGAAGA 1952 1963 + intron 1 9.17E-06 0.00524
22 AGAGAGAGGAGA 1986 1997 + intron 1 6.45E-06 0.00524
5 AGAAAGAGGAGA 2003 2014 + intron 1 9.17E-06 0.00524
AAAGAAGGAAGA 3878 3889 - intron 2 4.36E-06 0.00524
LsPLA2GL16-1 
(3286)
Venom gland similar 
to pancreas
1.218 1.218 0
AGAGAGGGAAGA 387 398 + intron 1 2.15E-07 0.00111
5 AGAGAGAGAAGA 404 415 + intron 1 9.17E-06 0.00524
133 AGAGAGAGGAGA 549 560 + intron 1 6.45E-06 0.00524






Table 2-3. Sequence and location of AG-rich motifs in snake metalloproteinase and housekeeping genes 
Species Gene (bp) Expression pattern




















AGAAAGTGGAGA 82126 82137 -
exon 3-intron 3 
boundaries
4.58E-07 0.06
2446 AGAAGGGGAAGA 79669 79680 + intron 4 1.63E-06 0.0854
24984 AGAGAATGGAGA 54674 54685 + intron 14 7.66E-07 0.06
2659 AGAGGGTGGAGA 52003 52014 - intron 14 1.47E-06 0.0854




0.029 0 0.029 AAAGAGGGGAGA 156098 156109 + intron 9 6.27E-07 0.06











Table 2-4. Location and frequency of AG-rich motifs in other snake genes 
Species Toxin family Gene (bp)















Trocarin D (16142) 30 N.A 0 0.867 0.434 0.434 intron 1





PCCS (10022)4 80 N.A 0 1.497 0.798 0.698 intron 1




LsPLA2GL1-1 (4415) 300 N.A 1 4.758 4.531 0.227 intron 1,2




S3444.1 gene 2 (99495)1 300 1 0 0.040 0.020 0.020
intron 4, 14, exon 3-
intron 3 boundary
S3444.1 gene 3 (34926)2 1 2.5 0 0.029 0 0.029 intron 9
S142.1 gene (21585)3 1 6 4 0 0 0 None
Housekeeping 
genes
SDHA (45187) 0.022 0.022 0 intron 1
GAPDH (5072) 0 0 0 None
TBP (12503) 0 0 0 None
RPL13A (6992) 0 0 0 None
ACTG1 (3082) 0 0 0 None
 
1. Gene similar to Zinc metalloproteinase-disintegrin stejnihagin-A; 2. Metalloproteinase-disintegrin VMP-III; 3. Disintegrin and 
metalloproteinase domain-containing protein 10. 4. The complete gene sequences of PCCS and PFX1 are not available, hence AG-rich 




In this chapter, Ins 2.2.4 of trocarin D intron 1 was characterized as a model to understand the 
essential structure for silencing cis-elements and their roles in regulating venom gland-specific 
expression of trocarin D, using serial deletion and site-directed mutagenesis in both mammalian 
cell lines and primary unmilked snake venom gland cells. From these initial results, Ins 2.2.4 is 
the smallest, most potent silencing region, which turns-off (>95%) the gene expression. Multiple 
silencing elements in Ins 2.2.4 acting synergistically to repress gene expression. After analyzing 
the sequences, we delineated the silencing effects to clustered AG-rich motifs in Ins 2.2.4 and 
showed that the synergism between these AG-rich motifs is essential for silencing function. Such 
multiple AG-rich sequences in tandem are known to repress gene expression (Déjardin et al., 
2005; Sipos et al., 2007). 
Interestingly Ins 2.2.4 containing clustered AG-rich motifs are similar to polycomb response 
elements (PREs) (Table 2-5). They recruit polycomb group protein complexes to target genes 
involved in various aspects of cell physiology and identity, including cell differentiation, 
reprogramming of stem and somatic cells, and response to environmental stimuli in Drosophila 
and vertebrates (Di Croce and Helin, 2013; Kerppola, 2009; Lanzuolo and Orlando, 2012; Lee et 
al., 2006). They are composed of a complex array of transcription factor binding sites, which 
function together (Kassis and Brown, 2013a). Although the precise combination of DNA 
sequences/transcription factors required for PRE activity are not clearly understood, studies in 
Drosophila have identified several transcription factors that bind to PRE sites. They include Pho 
(homologue of YY1), Dsp1 (homologue of HMGB2), Spps (homologues of Sp1, Sp3 and Sp4), 
GAF, Pipsqueak, Zeste and Grh (Lanzuolo and Orlando, 2012). A putative human PRE located 
between HOXD11 and HOXD12 genes contains YY1, HMGB2, Sp3 and GAF binding sites 
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(Table 2-5) and recruits polycomb group proteins to this site (Woo et al., 2010). Ins 2.2.4 has 
five clustered AG-rich motifs, and these motifs contain binding sites of above transcription 
factors (GAF and YY1 in motif 1: AGAGAATGGAGA; HMGB2 in motif 2: 
AGAAAGGGAAAA; GAF in motif 3: AGAGAGGGGAGA; GAF and Sp1/3 in motif 4: 
AGAGGGTGGAGA). In addition, we have found three HMGB2 sites between motifs 2 and 3. 
As AG-rich motifs in Ins 2.2.4 function synergistically similar to PREs, it would be interesting to 
evaluate whether polycomb repressive complexes play crucial role in silencing of TroD 
expression. 
 Silencing elements play a key role in gene regulation, and some have been described in several 
species (Maston et al., 2006; Ogbourne and Antalis, 1998). These silencing elements exhibit 
their function in a context-dependent or a context-independent manner. As second category of 
silencing elements, Ins 2.2.4 shows both promoter-independent and cell-type-independent 
silencing effects.  It has strong silencing potency on its native (VERSE; 50- to 100-fold) and 
heterologous promoter (CMV; 15- to 20-fold) in CHOK1, HEK293T and HepG2 cell lines (Fig. 
2-3 and 2-9). By using bioinformatics tools, we have identified similar AG-rich motifs clusters as 
the ones identified in trocarin D in some toxin genes (TroD, PCCS, LsPLA2GL1-1 and 
metalloproteinase S3444.1 gene 2) but not their physiological counterparts (TrFX, PFX1, 
LsPLA2GL16-1, S3444.1 gene 3 and S142.1) and housekeeping genes (SDHA, GAPDH, TBP, 
RPL13A and ACTG1). Considering these AG-rich regions act as promoter-independent silencing 
elements for VERSE and CMV promoters, the identified AG-rich motifs in genes of these toxins 
may be one class of common regulatory elements for venom gland-specific toxin expression.   
As the identified silencing cis-elements in intron 1 of trocarin D belongs to the snake genome 
and function in the snake tissues, they should be ideally characterized in snake non-venom gland 
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tissues for its repressive activity. However, there are two limitations for this: i) no stable snake 
cell lines are available; ii) the culture of primary snake non-venom gland cells has not been 
successful so far. As unmilked venom gland cells have low venom producing activity (Paine et 
al., 1992; Rotenberg et al., 1971). Therefore, the silencing cis-elements in Ins 2.2.4 of trocarin D 
intron 1 was initially characterized in primary unmilked venom gland cells and mammalian cell 
lines. As the activities of the silencing cis-elements were comparable between unmilked venom 
gland cells and mammalian cell lines, mammalian cell lines were used as substitute models to 
characterize the silencers. To prove that the silencing cis-elements are tissue- and time-specific 
regulatory elements, it is better to characterize their function in venom producting tissues 
(milked venom gland cells) as well. As a support, two preliminary experiments have been done 
in one day milked venom gland cells and four day milked venom gland cells respectively. The 
preliminary results have shown that the silencing cis-elements were repressed in the milked 
venom gland cells. Hence, the identified silencing cis-elements in Ins 2.2.4 of trocarin D intron 1 
are responsible for trocarin D tissue- and time-specific expression.  
As described in chapter 1, VERSE accounts for up-regulating expression level of trocarin D, and 
Ins 2.2.4 is responsible for silencing trocarin D expression in non-venom gland tissues. However, 
the previous study did not characterize the essential silencing cis-elements located in Ins 2.2.4. 
This thesis has shown the molecular details for repression of trocarin D expression. Synergism 
between two AG-rich motif sequences is essential for silencing the expression of a snake venom 
toxin gene, trocarin D, in non-venom producing tissues. In addition, the identified AG-rich 
sequences in Ins 2.2.4 of trocarin D intron 1 also exist in regulatory regions of other snake toxin 
genes. Hence, AG-rich sequences may be a common regulatory elements accounting for spatial- 
and temporal- specific expression of trocarin D and possible other venom toxins. This will help 
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us to understand the molecular details which play important roles during the recruitment of 





















Table 2-5. Comparison of Ins2.2.4 with known PREs (Brown et al., 2005; Cabianca et al., 2012; Déjardin and Cavalli, 2004; 







Sequence and location of binding sites in PRE
Drosophila
Ultrabithorax 185
Intron 2 of 
Bithoraxoid
Pho: (G/A)CCAT/ATGGC; GAF: GAGA/GAGAG. Function of these sites 










Pho: ATGGC/GCCAT; GAF: GAGAG/CTCTC; Zeste: YGAGYG;  Dsp1: 




Pho: ATGGC/GCCAT; GAF: CTCTC/GAGAG; Dsp1: TTTTC; Zeste: 
YGAGYG; Sp1/KLF:  (G/A)(G/A)GG(C/T)G. Function of these sites have 
been tested.
Snake Trocarin D (Ins2.2.4) 193
Intron 1 of
trocarin D
YY1: ATGG/GTGG; GAF: GAGA/GAGAG; Sp1/KLF:AGGGTG; HMGB2: 
GAAAA. Function of these sites have been tested. 
Human





YY1: ATGGA/GCCAC/GCAGCT/CCGCCC Function of these sites have 
been tested. 
















These sites are predicted based on the consensus sequence. This 
region is able to recruit polycomb group proteins.
1  2       3 4  5   
 
Grey bars represent the PREs; yellow bars represent Pho or YY1 binding sites; green bars represent GAF binding sites; blue bars 
represent Dsp1 or HMGB2 binding sites; purple bars represent Spps or Sp1/KLF family transcription factor binding sites; red bars 








Identification and functional characterization 









Transcription is activated or repressed through the recruitment of specific 
transcription factors to the regulatory cis-elements. As cells from different tissues 
of an organism have the same genome, the set of cis-elements in different tissues 
is identical. One mechanism for regulating tissue-specific gene expression is the 
availability and activity of specific transcription factors among various tissues. 
Therefore, to understand the molecular details of transcriptional regulation, it is 
important to identify the transcription factors binding to the cis-elements and 
understand how those interactions cause activation or repression of the 
transcription.  
As described in Chapter 2, multiple silencing cis-elements (Ins2.2.4.1 and 
Ins2.2.4.2) in insertion 2 of trocarin D intron 1 region account for the 
transcription repression of the gene in non-venom gland tissues and unmilked 
venom gland cells.  Several AG-rich motifs, which act synergistically, have been 
identified in these cis-elements. The ability of these silencing elements in 
repressing the activity of a heterologous promoter CMV and the presence of 
similar AG-rich motifs in non-coding regions of other toxin genes implies that 
these AG-rich motifs are probably common regulatory elements (Chapter 2). Such 
multiple AG-rich sequences in tandem are known to repress gene expression 
(Déjardin et al., 2005; Sipos et al., 2007). However, these AG-rich sequences are 
not the same with previously identified AG-rich motifs. Therefore, it would be 
interesting to identify the transcription factors which interact with the silencing 
cis-elements. This will help to explain how these transcription factors turn off the 
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trocarin D expression in non-venom gland cells. In this chapter, I have identified 
the transcription factors that bind to these cis-elements using DNA affinity 
chromatography and Electrophoresis Mobility Shift Assay (EMSA). Among the 
identified transcription factors, HMGB2, YY1 and Sp3 were confirmed to be 
functionally important in repressing trocarin D expression.   
3.2 Materials and Methods 
3.2.1 Nuclear extraction from HEK293T cells 
Nuclear extracts from HEK293T cells were prepared according the previous 
method (Dignam et al., 1983) with minor modifications. Approximately 1×108 
HEK293T cells were harvested by centrifugation, washed, and re-suspended in 5-
times packed cell pellet volume of hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 
mM MgCl2, 10 mM KCl,0.1 mM ABESF, 1 mM DTT,1 mg/ml leupeptin, 1 
mg/ml peptastatin A), which causes the cells to swell. Subsequently, the cells 
were washed and then lysed with a homogenizer. 
The nuclei were collected by centrifugation, the cytoplasmic supernatant was 
decanted, and the nuclear pellet was re-suspended in equal nuclei pellet volume of 
hypertonic salt buffer (25% glycerol, 20 mM HEPES, pH 7.9 ,1.5 mM MgCl2, 
420 mM NaCl, 0.2 mM EDTA, 0.4 mM ABESF,1 mM DTT, 1 m/ml peptastatin 
A, 1 mg/ml leupeptin. Add PMSF and DTT immediately before use). Then the 
nuclei suspension was lysed by homogenization. After shaking the resulting 
suspension at 100 rpm for 30 min to 1 h at 4°C to allow extraction of transcription 
factors, the nuclei were centrifuged again, and the resulting supernatant or extract 
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was used in DNA affinity chromatography experiments. Generally, 1×108 cells 
generate nuclear extract 900 µl at 5-8 mg/ml.  
3.2.2 Systematic optimization of Electrophoretic Mobility Shift Assay (EMSA) 
condition 
Fluorescent labeled oligonucleotides are purchased from Sigma Aldrich. Single 
stranded probes were annealed to double-stranded oligonucleotide probes in 
annealing buffer (20 mM Tris-HCl pH 8.0; 50 mM MgCl2; 50 mM KCl). EMSA 
was performed as follows: briefly, nuclear extract (5 mg/ml, 4 μl) was mixed with 
100 nM of fluorescent labeled oligonucleotide in 20 μl 1×EMSA buffer (20 mM 
HEPES, pH 7.9, 0.1 mM EDTA, 50 mM KCl, 1 mM DTT, 5% glycerol) 
containing 50 μg/ml poly dI:dC. After DNA-protein complex formed at room 
temperature for 15 min, the complex was separated on a pre-electrophoresed 10% 
(w/v) native polyacrylamide gel (10 cm) in 1 × TG buffer at 200 volts at 4 ºC and 
visualized by Typhoon 9410 imager (Amersham Biosciences). EMSA optimized 
conditions were determined when the formation of DNA-protein complex was not 
disrupted by added agents which diminish non-specific DNA binding. First, a 
two-fold serial dilution of poly dI:dC from 160 to 2.5 ng/μl was added. In the 
range of 10 to 80 ng/μl of poly dI:dC there is no significant interference with 
complex formation and 50 ng/μl of poly dI:dC was chosen for economic reasons. 
Finally, Sp1 mutant DNA (5′-ATTCGATCGGTTCGGGGCGAGC-3′) was added in two-
fold dilution from 10,000 nM to 1000 nM and 1000 nM was selected as the 
optimal concentration. Taken together, the optimized EMSA conditions are as 
follows: HEK293 nuclear extract is diluted four-fold in 1×EMSA buffer  
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containing 50 ng/μl poly dI:dC and 1000 nM of Sp1 mutant DNA to enhance 
binding specificity.  
3.2.3 EMSA competition assay  
In competition experiments, 100-fold excess unlabeled double stranded specific 
and non-specific competitors were pre-incubated with the nuclear extract for 15 
min at room temperature (25 ºC) prior to the addition of labeled probes.  NFkB 
consensus oligonucleotide (5'–AGTTGAGGGGACTTTCCCAGGC–3') is used as non-
specific competitor. 
3.2.4 DNA affinity chromatography 
Coupling biotin labeled oligonucleotides to streptavidin beads and pre-clean 
nuclear extract 
5’ biotin-labeled oligos were designed based on the sequence of AG-rich motifs 
(motif 1: 5'-GGAAAAGAGAATGGAGAATTTA-3'; motif 4: 5'- GACTAAGAGGGTGGAGATTAAG-
3'; mutant motif 1: 5'-GGAAAAGCTCTCTCCGAATTTA-3'; mutant motif 4: 5'-
GACTAAGCTATCTTCGATTAAG-3'). 150 pmol of annealed 5' biotin-labeled oligo was 
then attached to 200 µl streptavidin magnetic particles in 0.1 TE buffer (10 mM 
Tris-HCl, 1 mM EDTA, 100 mM NaCl pH8.0). Magnetic particles were 
incubated with biotin-labeled DNA for 30 min at room temperature with gentle 
shaking. The binding efficacy was evaluated by comparing the concentration of 
DNA in the supernatant before and after coupling to streptavidin beads. (The 
binding efficacy usually is around 70% indicating 100 pmole DNA is coupled to 
the beads).  This protein-binding oligo/magnetic particle complex was used as bait 
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to purify specific DNA binding proteins. HEK293T nuclear extract was first 
diluted with equal volume of HEPES buffer (20 mM HEPES, 12.5% glycerol, 0.1 
mM EDTA, 0.5 mM DTT, pH7.9). To reduce the background, streptavidin 
binding proteins from the nuclear extract were removed by incubating the crude 
nuclear extract with streptavidin magnetic beads and 1.5 nmol Sp1 mutant 
oligonucleotide and 30 g poly dI:dC for 30 min at 4 ºC with gentle shaking.  
 Purification of specific interacting transcription factors from pre-cleaned 
nuclear extract 
To purify the interacting transcription factors, the protein-binding oligo/magnetic 
particle complexes were mixed with 300 μg of pre-cleaned nuclear extracts for 1 h 
at 4 ºC with gentle shaking. 10 μg poly dI:dC (1 μg/μl) was also added to reduce 
the binding of nonspecific transcription factors. Washing was carried out with 3 
volumes of buffer A (20 mM HEPES; 100 mM NaCl; 12.5% glycerol; 0.1 mM 
EDTA; 0.5 mM DTT) on a magnetic stand for 3-4 times. Buffer A with 1 M NaCl 
was used to elute the transcription factors which bound to the oligonucleotides. 
The eluted proteins were analyzed on SDS-PAGE. Protein bands were visualized 
by Coomassie blue staining. 
To distinguish specific and non-specific binding proteins for motifs 1 and 4, we 
performed comparative DNA affinity chromatography (Fig. 3-2). The amount of 
individual proteins in eluates from each group was estimated using emPAI value 
provided by Mascot database (Ishihama et al., 2005). The proteins that were 
found in lower amounts in the eluates from mutant motif 1-tagged beads 
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compared to that from motif 1-tagged beads were identified as specifically bound 
to motif 1. Similarly, we also compared the protein content between different 
groups for motif 4 (Fig. 3-3 and Fig. 3-5). 
3.2.5 Liquid chromatography-mass spectrometry for proteins purified by 
DNA affinity chromatography 
Tryptic peptides were analyzed on the Liquid Chromatography ElectroSpray 
Ionization Quadruple Time-Of-Flight Tandem Mass Spectrometer (AB Sciex 
Triple TOF 5600, Framingham, MA, USA). The peptides with an m/z from 350-
1250 and charge state from 2-4 were selected by the quadruple detector. 
Sequences of selected charged peptides were determined using TOF. All MS/MS 
data were analyzed using Mascot (Matrix Science, London, UK; version 2.3.01). 
The search was set up for the Swissprotapr_20150420 human database (20,205 
sequences) with trypsin as the digestion enzyme. The mass tolerance for fragment 
ion was set at 0.4 Da while the error bias threshold for a parent ion was 200 ppm. 
Acetylation of cysteine on the N-terminal, carbamidomethylation of cysteine on 
the C-terminal, and oxidation of methionine were specified in Mascot as variable 
modifications.  
Results were scored using the probability-based Mowse score. The score 
threshold to achieve p < 0.01 was set by the Mascot algorithm and was based on 
the size of the database used in the search. Protein scores were derived from ion 
scores on a non-probabilistic basis. We accepted the protein identification when 
Mascot scores (40) were above the statistically significant threshold (p < 0.01) 
and the proteins with two unique peptides matched were considered as high 
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confidence. Proteins that contained similar peptides and could not be 
differentiated based on MS/MS analysis alone were grouped to one family. 
Further, the absolute protein amount after normalization were estimated and 
compared using emPAI-based concentrations (Ishihama et al., 2005). Only those 
showing different protein contents (Motif /Mut>1.2) were considered as motifs 1 
and/or 4 specific binding proteins.  
3.2.6 EMSA-SDS PAGE-Western blot assay 
EMSA reaction mixture (100 μl) containing ≥0.5 pmol of complex were loaded 
into each well. After the native PAGE, the specific DNA-protein bands were cut 
and transferred into the denaturing buffer (125 mM Tris-HCl pH 6.7, 20% SDS, 
0.1% bromophenol blue) for 15 min at room temperature. The denatured gel 
pieces were sealed on polymerized SDS-PAGE using 1% agarose in 125 mM 
Tris-HCl (pH 6.8) buffer. The gel was run at constant 150 V at 4 ºC. The proteins 
in the SDS-PAGE were transferred onto PVDF membrane in western blot transfer 
buffer at constant 200 mA at 4 ºC, and detected by respective antibodies. Western 
blot was performed with antibodies for YY1 (H-414, sc-1703), Sp3 (D-20, sc-644) 
and TBP (N-12, sc-204) were purchased from Santa Cruz Biotech (Santa Cruz, 
CA, USA). Antibody for HMGB2 (Ab67282) were purchased from Abcam (Hong 
Kong, China). 
3.2.7 Knock down of HMGB2, YY1 and Sp3 with small interference RNA 
HMGB2, YY1 and Sp3 expression was inhibited in HepG2 cells by transfection 
with small interfering RNA (siRNA) targeting the specific mRNA. Cells were 
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plated onto 6-well plates or 96-well plates in DMEM containing 10% FBS. When 
cells grew to 30% confluence, they were transfected with HMGB2 (40 nM), YY1 
(20 nM) or Sp3 (20 nM) siRNA (or scrambled control siRNA) using 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). The reduction in the 
expression of specific proteins was confirmed by western blot analysis 72 h after 
transfection. Subsequently, luciferase reporter vectors were transfected and the 
luciferase activity was measured after 24 h. 
The siRNA used in this experiment are listed as follows: 
Sp3 siRNA1 (Hs_SP3_1), HMGB2 siRNA 1 and 2 (Hs_HMGB2_6 and 
Hs_HMGB2_7) were purchased from Qiagen (Valencia, CA, USA). Sp3 siRNA2 
and YY1 siRNA1 were purchased from Sigma Aldrich (St. Louis, Missouri, USA) 
by using the following sequence (Sp3 siRNA2: 5’-
GCGGCAGGUGGAGCCUUCACUdTdT-3’; YY1 siRNA1: 5’-
CAUAAAGGCUGCACAAAGAUUdTdT-3’). YY1 siRNA2 (sc-36863) were purchased 
from Santa Cruz Biotech (Santa Cruz, CA, USA). 
 
3.3 Results 
3.3.1 The identified AG-rich motifs are important for the specific 
transcription factor binding in vitro.  
To verify the importance of these AG-rich motifs for specific protein-DNA 
complex formation, I performed EMSA competition assay. Cyanine 5 labeled 
98 
 
motifs 1-5 were individually incubated with HEK293T nuclear extract and then 
run on a native gel. The positions of Cyanine 5 labeled oligonucleotides were 
detected with a fluorescence scanner. If any proteins bound to the labeled 
oligonucleotides and form a DNA-protein complex, the mobility of the labeled 
oligonucleotides will be shifted in the gel. We have found that all motifs form 
several bands with HEK293T nuclear extracts and these bands were numbered as 
bands 1-6 according to the mobility (Fig. 3-1). Additionally, a competition assay 
was performed to evaluate whether a band (representing a DNA-protein complex) 
is specific to the corresponding motifs. If it is specific, the binding of labeled 
oligonucleotides with the corresponding proteins will be prevented by the 
unlabeled specific oligonucleotides, but not the unlabeled irrelevant or mutant 
oligonucleotides. Class A motifs form more specific DNA-protein complexes 
(motif 1: complexes 2, 4, 5 and 6; motif 3: complex 3; motif 4: complexes 2-6), 
compared to class B motifs (motif 2: complex 6; motif 5: no specific complex). 
As expected, different class A motifs form several specific complexes with 
identical mobility (for example, complex 2, 4, 5 and 6 for motifs 1 and 4; complex 
3 for motifs 3 and 4). Indeed, specific complexes formed by motifs 1 are 
competitively prevented by 100-fold excess of unlabeled other two class A motifs 
(motifs 3 and 4), and similar results were found in competition experiments of 
motifs 3 and 4 (Fig. 3-1). Interestingly, motif 2 (a class B motif) also forms 
specific complex 6. The formation of this complex was completely prevented by 
100-fold excess of class A motifs (Fig. 3-1). This suggests that transcription 
factors in complex 6 bind to both class A and class B motifs. 
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Despite forming similar complexes, the binding patterns of different motifs were 
not identical. According to the band intensity and mutual cross-competition 
pattern, motif 1 has the highest potential to form complex 2 and 4, while motif 4 
has the highest potential to form complex 3, 5 and 6 (Fig. 3-1). Thus, subtle 
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Figure 3-1. EMSA competition assay for AG-rich motifs. NFkB: nonspecific 
competitor; M1C-M5C: unlabeled motifs 1 to 5 oligonucleotides; M1MC-M4MC: 
unlabeled motifs 1 to 4 mutant oligonucleotides. Number 1-6 indicate the 
positional shifted bands.   
3.3.2. Purification and identification of transcription factors interacting with 
silencing cis-elements.  
As motifs 1 and 4 have the highest binding affinities for specific DNA-protein 
complexes, they are used as probes to identify specific transcription factors from 
HEK293T nuclear extracts by using DNA affinity chromatography. Nuclear 
extracts from HEK293T cells were used for DNA affinity chromatography for 
two reasons: 1) HEK293T cells exhibited similar repression pattern compared to 
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primary unmilked venom gland cells (Fig. 2-4); 2) HEK293T cells are easier to 
grow in sufficient quantity to get enough proteins for binding studies. After 
incubating nuclear extracts with motif 1 or motif 4-tagged beads and washing the 
unbound proteins, bound proteins were eluted using 1M NaCl buffer and 
separated on a 4-15% gradient SDS-PAGE. The protein bands were visualized by 
Coomassie blue staining. There are multiple protein bands in the motif 1 and 
motif 4 eluates (Fig. 3-3). These proteins were identified by in gel trypsin 
digestion followed by LC-MS analysis. 
One protein identified in both motifs 1 and 4 eluates is YY1 (sp|P25490). YY1 
has a mass of 44.7 kDa, and there are 12 unique peptides from motif 1 eluates 
sequenced by Q-TOF show significant homology to YY1 (Fig. 3-4B). These 
peptides form sequence coverage of 33% against the YY1 protein sequence 
(sp|P25940). According to the criteria mentioned in material and methods in this 
chapter, proteins with Mascot score >40 and contained at least 2 identified 
peptides are accepted. YY1 is a considered as a motif 1 binding protein. Similarly, 
proteins such as HMGB2, YY1, HDAC1, HDAC2, RCOR1 and NFAC1 were 
identified as motif 1 binding proteins (Fig. 3-5A), and HMGB2, YY1, Sp3, Sp1, 
KLF16, NFAC1 and ZBT8A, etc. as motif 4-associated proteins (Fig. 3-5B).  
To distinguish specific and non-specific binding proteins for motifs 1 and 4, I 
performed comparative DNA affinity chromatography (Fig. 3-3). The amount of 
individual proteins in eluates from each group was estimated using emPAI value 
provided by Mascot database (Ishihama et al., 2005). The proteins that were 
found in lower amounts in the eluates from mutant motif 1-tagged beads 
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compared to that from motif 1-tagged beads were identified as specifically bound 
to motif 1. Similarly, we also comopared the protein content between different 
groups for motif 4 (Fig. 3-3 and 3-5).  With two independent repetitions, we 
observed that YY1, RCOR1 and NFAC1 specifically bound to motif 1, and Sp3, 
Sp1, KLF16, YY1 and NFAC1 specifically bound motif 4 (Fig. 3-5 and Table 3-
1). According to the abundance in the eluates, we focused on Sp3 and YY1 as 
specific transcription factors in this study. DNA-affinity purified proteins were 
also subjected for western blot analysis and indeed, YY1 was identified as a 
specific binding protein for motifs 1 and 4, while Sp3 was a specific binding 
protein for motif 4 (Fig. 3-6). 
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Figure 3-2. Identification of motif specific binding proteins using DNA 



























Figure 3-3. SDS-PAGE of DNA affinity chromatography purified proteins. 
Motif 1 or 4 binding proteins were purified by DNA affinity chromatography and 
subjected to SDS-PAGE followed by Coomassie blue staining. Proteins that 
bound to motif 1, mut1 (A) and motif 4, mut4 (B). Motif 1 and Motif 4: Eluates 
purified by incubating HEK293T nuclear extracts with only motif 1 or 4 coupled 
magnetic beads; Mut1, Mut4: Eluates purified by incubating HEK293T nuclear 






1 MASGDTLYIA TDGSEMPAEI VELHEIEVET IPVETIETTV VGEEEEEDDD
51 DEDGGGGDHG GGGGHGHAGH HHHHHHHHHH PPMIALQPLV TDDPTQVHHH
101 QEVILVQTRE EVVGGDDSDG LRAEDGFEDQ ILIPVPAPAG GDDDYIEQTL
151 VTVAAAGKSG GGGSSSSGGG RVKKGGGKKS GKKSYLSGGA GAAGGGGADP
201 GNKKWEQKQV QIKTLEGEFS VTMWSSDEKK DIDHETVVEE QIIGENSPPD
251 YSEYMTGKKL PPGGIPGIDL SDPKQLAEFA RMKPRKIKED DAPRTIACPH
301 KGCTKMFRDN SAMRKHLHTH GPRVHVCAEC GKAFVESSKL KRHQLVHTGE
351 KPFQCTFEGC GKRFSLDFNL RTHVRIHTGD RPYVCPFDGC NKKFAQSTNL
401 KSHILTHAKA KNNQ
Yin and Yang1 Mass: 44713 pI: 5.80 Score: 1492 Peptide matched: 12
Protein sequence coverage: 33% Matched peptides shown in bold red
 
Figure 3-4. Identification of YY1 purified from motif 1 affinity 
chromatography by LC-MS/MS.  A) An MS/MS spectra of a tryptic peptide 
SYLSGGAGAAGGGGADPGNK identified from YY1 in the eluates of motif 1 
affinity chromatograph. B) Peptide mass fingerprinting of YY1 from motif 1 
affinity chromatography. The proteins from lane motif 1 (Fig. S4) were cut out for 
in-gel tryptic digestion and followed by LC-MS/MS identification. Database 
search shows one of the proteins to be YY1 with 33% reported sequence coverage. 




























































































































































































































































































Figure 3-5. Comparison of proteins purified by DNA affinity 
chromatography. Motif 1/ Mut1 represents the comparison of the amount of 
proteins purified by Motif 1 and Mut 1 affinity chromatography. Motif 4/ Mut 4 
represents the comparison of the amount of proteins purified by Motif 4 and Mut 
4 affinity chromatography. The patterns with different intensities of black dots 
(from low to high) indicate the ratios are <1.2, 1.2-2, 2-5, and above 5, 








Figure 3-6. Western blot analysis of YY1, Sp3 and HMGB2 purified by motif 
1 and 4 affinity chromatography. Motif 1 or 4 binding proteins were purified by 
DNA affinity chromatography and subjected to SDS-PAGE followed by western 
blot. Antibodies for YY1, Sp3 and HMGB2 were used to identify those proteins 
in the purified mixture. Motif 1, 4: Eluates purified by incubating HEK293T 
nuclear extracts with only motif 1 or 4 coupled magnetic beads; Mut1, 4: Eluates 





Table 3-1. Identification of HMGB2, YY1 and Sp3 as motif 1 and/or motif 4 
binding proteins 
Protein name Experimental group
Experiment 1 Experiment 2 Experiment 1 Experiment 2
Motif 1 Mut 1 Motif 1 Mut 1 Motif 4 Mut 4 Motif 4 Mut 4
sp|P26583|HMGB2_HUMAN
MW (kDa) 24019
Number of matched 
peptides
11 11 3 6 9 14 6 7
Coverage 45% 37% 11% 33% 29% 41% 23% 23%
Protein score 1231 1020 143 288 593 1411 318 375
emPAI X weight% 0.0113 0.0091 0.0046 0.0032 0.0156 0.0232 0.0121 0.0248
sp|P25490|TYY1_HUMAN
MW (kDa) 44685
Number of matched 
peptides
12 0 5 0 9 0 1 0
Coverage 33% 0% 16% 0 21% 0 3% 0%
Protein score 1492 0 201 0 304 0 50 0
emPAI X weight% 0.0053 0 0.0058 0 0.0064 0 0.0008 0
sp|Q02447|SP3_HUMAN
MW (kDa) 81876
Number of matched 
peptides
2 0 4 2
Coverage 3% 0% 6% 3%
Protein score 342 0 187 213
emPAI X weight% 0.0012 0 0.0035 0.0027
 
3.3.3 The identified candidate transcription factors are present in the specific 
DNA-protein complex. 
To evaluate whether the identified transcription factors are present in the specific 
DNA-protein complexes, EMSA-SDS PAGE-Western blot has been performed 
for complexes formed by motifs 1 and 4. To ensure the protein can be visualized 
by western blot, 300 l mixture containing motif 1 or 4 with nuclear extract was 
run on a big native PAGE (Fig. 3-7). The specific DNA-protein complexes were 
cut, denatured and run on a SDS-PAGE. Proteins in the complex were identified 
using western blot. To eliminate the possibility that a protein with the same 
electrophoretic mobility as the specific DNA-protein complex could be 
misidentified as a binding transcription factor, samples containing either only the 
nuclear extract without labeled DNA or nuclear extract with non-related DNA 
oligonucleotides were used as negative controls.  
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As figure 3-6 shows, YY1 was identified in the specific complexes 2 and 4 
formed by motifs 1 and 4 compared to the control, which is consistent with the 
previous observation that AG-rich motifs bind identical proteins (Fig. 3-1). 
Similarly, Sp3 was identified in the specific DNA-protein complex 3 formed with 
motif 4 (Fig. 3-7C). YY1 and Sp3 were not identified in the specific comoplexes 
5 and 6 formed with motifs 1 and 4. HMGB2 was present in the specific DNA-
protein complex 6 formed by motifs 1 and 4 as well as the sample containing 
nuclear extract with unrelated DNA oligonucleotides, but it is absent in other 
complexes (Fig. 3-7). This suggests that HMGB2 binds to both specific motif and 
unrelated sequences, and other transcription factors might be responsible for the 
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Figure 3-7. Identification of specific transcription factors for AG-rich motifs. 
Motifs 1 and 4 EMSA was performed (A), and the specific complexes were 
denatured and resolved in SDS-PAGE followed by western blot analysis (B). 
YY1, Sp3 and HMGB2 were identified in motif 1 and/or motif 4 specific shifted 
complexes (B). NE: HEK293T nuclear extracts; NE + NS: HEK293T nuclear 
extracts incubated with unlabeled non-specific oligonucleotides; NE + motif 1 or 
4: HEK293T nuclear extracts incubated with labeled motif 1 or 4. 
 
3.3.4 Confirmation of biological functions of the identified transcription 
repressors. 
HMGB2, YY1 and Sp3 are known to bind to AG-rich motifs and regulate gene 
expression (Birnbaum et al., 1995; Gabellini et al., 2002; Grace Gill, 2002; Hagen 
et al., 1994; Hyde-DeRuyscher et al., 1995; Shi et al., 1991). To examine their 
silencing function in vivo, siRNA knockdown experiments were performed for 
these proteins in HepG2 cell line. The knockdown efficiency for each protein was 
evaluated by western blot and was found to be 57%-69% (Fig. 3-8A-C). The 
relative luciferase activity of Ins 2.2.4, Ins 2.2.4.1 and Ins 2.2.4.2 constructs 
109 
 
increased from 0.9%, 4.6% and 5.4% to 2.0-2.6%, 6.8-7.9%, and 10.3-11.3% in 
the YY1 knockdown cells compared to the control cells (Fig. 3-8D). Similarly, it 
was observed that knockdown of HMGB2 lead to higher luciferase activity of 2.8-
4.1%, 8.8-12.4%, and 10.0-10.5% (Fig. 3-8E). In Sp3 knockdown cells, only the 
silencing effect of Ins 2.2.4 and Ins 2.2.4.2 were disrupted (Fig. 3-8F), as Ins 
2.2.4.1 does not contain Sp3 binding site. Individual knockdown of HMGB2, 
YY1 and Sp3 did not completely restore the expression. This could be due to (i) 
the proteins leftover after the knockdown are sufficient to repress the gene 
expression and/or (ii) knockdown of one protein in the repressor complex is not 
enough to overturn the repression. Thus, all three transcription factors appear to 
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Figure 3-8. siRNA-mediated knockdown of HMGB2, YY1 and Sp3 impairs 
the repressor activity. The knockdown efficiency of HMGB2 (A), YY1 (B) and 
Sp3 (C) in HepG2 cells compared to the control was analyzed using western blot. 
Western blot was performed after 72 h following transfection with siRNA. TATA 
box binding protein (TBP) was used as a loading control. Repressive activity of 
identified silencing elements in HMGB2 (D), YY1 (E) and Sp3 (F) knockdown 
HepG2 cells, respectively. HepG2 were transfected with luciferase reporter 
vectors after 48 h following the transfection with the HMGB2, YY1, Sp3 or 
control siRNA. The luciferase activity was analyzed after 72 h following the 
siRNA transfection. The results are represented as relative percentage to that of 
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VERSE promoter which was taken as 100%. Each data point is the mean ± S.E. of 
at least three experiments, each done in triplicate. * indicates P<0.04 (one-sided t 




We identified motifs 1-4 bind similar specific transcription factors by using an 
EMSA competition assay, and different motifs have distinct affinity to certain 
transcription factors. By using DNA affinity chromatography followed by LC-
MS/MS, we have found transcription factors binding to motifs 1 and 4, such as 
HMGB2, YY1, HDAC1, HDAC2, RCOR1, Sp3, Sp1, KLF16, NFAC1 and 
ZBTBA. By comparing proteins binding to mutant motifs and wild type motifs, 
YY1, RCOR1 and NFAC1 were identified as motif 1 specific proteins with two 
independent repetitions. Similarly Sp3, Sp1, KLF16, YY1 and NFAC1 were 
observed to specifically bound to motif 4. As mentioned in Chapter 2, AG-rich 
motifs in Ins 2.2.4 contain binding sites of above transcription factors (YY1 in 
motif 1: AGAGAATGGGAGA; HMGB2 in motif 2: AGAAAGGGAAAA; YY1 
and Sp1/3 in motif 4: AGAGGGTGGAGA). In addition, we have found three 
HMGB2 sites between motifs 2 and 3. Hence, HMGB2, YY1 and Sp3 are 
probably important for silencing function. Indeed, YY1 and Sp3 have been shown 
to form specific complexes with motif 1 and/or motif 4, while HMGB2 binds to 
both non-specific and specific oligonucleotides. siRNA mediated knockdown 
experiments have confirmed that HMGB2, YY1 and Sp3 played important roles 
in gene repression by Ins 2.2.4 and its sub-segments. In this section, I will 
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describe the structural and functional characteristics of HMGB2, YY1 and Sp3 
and discuss the possible repression mechanism.  
YY1 
YY1 is a ubiquitous and multifunctional zinc-finger transcription factor which 
exerts its effects on genes via initiation, activation or repression of transcription 
depending upon the context in which it binds. Besides the human YY1, the 
homologous proteins of YY1 were identified in different eukaryotic organisms 
and yeast (Shi et al., 1991, 1997; Wieschaus et al., 1984; Yang et al., 1996). All 
these homologous YY1 proteins in human and other animals have two domains in 
the middle of the protein (amino acid position 203-226 and 250-281 in the human 
YY1, respectively), and one DNA-binding zinc finger domain at the C-terminus 
(aa 298-414). The two domains in the middle, Domains I and II, are located 
within the region previously known as the spacer between several N-terminal 
domains and C-terminal DNA-binding domain (Thomas and Seto, 1999). These 
two domains are found in the YY1-related sequences of most, but not all, 
vertebrates and insects. However, the zinc finger domain is found in all the YY1-
related sequences with high levels of sequence conservation, ranging from 66 to 
100% similarity. The relative positions of these three protein domains and the 
consensus binding sites ‘CCAT or ATGG’ are also conserved among all the 
identified sequences.  
YY1 was first identified to be modulated by adenovirus-derived E1A, a protein 
that activates the AAV P5 promoter (Chang et al., 1989). YY1 is a transcription 
activator in the presence of E1A, but converts to a transcriptional repressor in its 
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absence (Shi et al., 1997). It has been proposed that this phenomenon is due to the 
conformational change of YY1 through covalent modification, or a direct 
interaction between YY1 and E1A-type accessory protein. This mechanisms is yet 
to be studied. Analysis of GLA4 fusion protein revealed repression of 
transcription by the C-terminus domain (aa 298-397), and sequences within the 
zinc-finger motifs and glycine-rich residues between amino acids 157 and 201, 
using a chlorampenicol acetyl transferase (CAT)-based reporter system driven by 
a promoter rich in GAL4-binding sites. While the N-terminus regions (aa 43-53) 
were identified to contribute to the activation of transcription.  
There are several mechanisms of YY1-mediated transcriptional repression. It has 
been shown that many promoters contain sequences of YY1 sites that overlap 
with activating factors, such as serum response element (SRE) of the cellular 
FBJ/FBR osteosarcoma (s-fos) gene, alpha-actin muscle regulaotry elements 
(MREs), and the muscle creatine kinase CarG motif (Shi et al., 1997). 
Competition of YY1 with the promoter results in transcriptional repression, and it 
is reversed by the alternative competition/displacement of transcriptional 
activators. In other cases, YY1 represses transcription via interference with the 
function of transcriptional activators. One example is c-fos promoter, which not 
only contains overlapping sites for YY1 and SRE, but also possesses two 
additional YY1 sites between the calcium/cyclic AMP response element (CRE) 
and the TATA box. YY1 interferes the activation mediated by CRE binding 
protein (CREB) through interaction of the zinc-finger motifs on YY1 and the 
basic leucine zipper region (bZIP) on the CREB in either binding site-dependent 
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or binding site-independent manner (Galvin and Shi, 1997; Guo et al., 1997). In 
addition to the above mechanisms, YY1 also recruits corepressors that either 
directly act to repress transcription or induce chromatin remodeling to further 
assist YY1-mediated DNA interaction and repression (Thomas and Seto, 1999).  
In terms of activation, it is possible that YY1 interacts with other cofactors and 
undergoes conformational changes that unmask the N-terminal activation domain 
(Thomas and Seto, 1999). YY1 may also activate transcription via recruiting other 
transcription activators. It can either induce the cofactors to target promoter and 
activate transcription directly or interact with coactivators with histone 
acetyltransferase activity, such as CBP and p300 (Lee et al., 1998).    
Sp3 
GC and GT boxes (5'-GGGGCGGGG-3' and 5'-GGTGTGGGG-3') are important 
cis-elements, which regulate transcription of many tissue-specific, viral, and 
inducible genes (Bouwman and Philipsen, 2002; Philipsen and Suske, 1999; 
Suske, 1999). Sp1 is the first transcription factor identified in mammalian cells 
that binds GC-rich sites within the SV40 promoter via three zinc-finger motifs. 
Subsequently, transcription factors with similar DNA-binding domains were 
identified in many different organisms, thereby defining a novel family of Sp1-
like proteins or Krupple-like factors (Sp1-like/KLF) (Brown et al., 2005; Hagen et 
al., 1992; Kassis and Brown, 2013b; Kingsley and Winoto, 1992). In this family, 
Sp1, Sp2, Sp3 and Sp4 contain similar domain structures, forming a subgroup. 
However, Sp2, has a different consensus binding site and evolutionary history 
than the other Sp family members.  
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Within this subgroup, Sp1 and Sp3 are ubiquitously expressed in multiple tissues. 
They share more than 90% homology in the DNA-binding domain, and similar 
domain structures. Both have a trans-activation domain consists of two sub-
domains (A and B) and a carboxyl-terminal domain (domain D) that are required 
for synergistic activation along with sub-domains A and B (Pascal and Tjian, 
1991). The glutamine-rich regions in sub-domains A and B are required for 
stimulating transcription, and the serine/threonine-rich regions next to the 
glutamine-rich regions are proposed to be involved in post-translational 
modification (Roos et al., 1997; Yang et al., 2001). They also share a domain C 
with highly charged amino acids, and the carboxyl-terminal of domain C has three 
Cys2His2 zinc "fingers", which are the GC-rich elements binding domains.  
Although Sp1 and Sp3 contain similar structures and bind to the same DNA-
binding sites, they exhibit distinct regulatory functions that depend on the 
promoter and cellular context (Bouwman et al., 2000; Yu et al., 2003). The major 
reason for the different functions is proposed to be the distinct location of 
inhibitory domains in Sp1 and Sp3; the domain is located at the N-terminus of 
Sp1, but in front of the zinc-finger domain of Sp3 (Dennig et al., 1996; Suske, 
1999). Interestingly, in addition to a long isoform 115 kDa, Sp3 has two short 
isoforms 80 kDa and 78 kDa that are products of different translational initiation. 
The two short isoforms do not have trans-activation A domain, but have the B 
domain and inhibitory domain. Increased levels of the Sp3 short isoforms has 
been suggested to account for decreased expression of human reduced folate 
carrier gene in multiple tumor cell lines (Rothem et al., 2004).  
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As mentioned earlier, a major distinction of Sp3 is its ability to both activate and 
repress transcription depending on the promoter context. SUMOylation of the 
lysine residue within the inhibitory domain of Sp3 regulates the dual nature of its 
function via changing its activity and subcellular location (Grace Gill, 2002; 
Sapetschnig et al., 2002). It has also been demonstrated that SUMOylated Sp3 
acts as a platform to recruit chromatin remodeler Mi2, heterochromatin protein 
HP1, chromatin-associated proteins L3MBTL1 and L3MBTL2, and histone 
methyltransferases SETB1/ESET and SUV4-20H. Recruitment of these factors by 
SUMOylated Sp3 is correlated with the formation of a repressive chromatin 
structure with modified histones H3K9me3 and H4K20me3 (Stielow et al., 2008a, 
2008b, 2010). Mutation of the SUMO acceptor lysine coverts Sp3 into a strong 
activator with a diffuse nuclear location (Grace Gill, 2002). In addition to indirect 
regulation of transcription, Sp3 also inhibits the transition of paused RNA 
Polymerase II to productive elongation via recruitment of phosphatases to the 
target genes (Valin et al., 2013).  
HMGB2 
High-mobility-group box family of proteins (HMGB) are one of three classes of 
high-mobility group (HMG) proteins, which are major non-histone nuclear 
proteins that associate with chromatin in eukaryotes (Agresti and Bianchi, 2003; 
Bustin, 1999, 2001; Thomas and Travers, 2001). The structures of HMGB 
proteins are highly conserved in higher eukaryotes. Each of them possesses  two 
L-shaped DNA-binding domains, termed HMG boxes A and B, and an acidic C-
terminal tail (Thomas and Travers, 2001). The HMG boxes are known to bind the 
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minor groove of DNA (Thomas and Travers, 2001), and are capable of bending 
DNA.  
HMGBs can activate transcription through several mechanisms. The first 
mechanism is that HMGBs modulate the binding of transcription factors to target 
sequences. In such cases, HMGBs interact with specific transcription factors, 
including Oct 2, p73 and Class I steroid hormone receptors. Once bound, HMGBs 
can bend the DNA and either stabilize the partner proteins on the target site or 
help the recruitment of other interacting proteins (Melvin et al., 2002, 2004; Stros 
et al., 2002; Verrijdt et al., 2002; Zwilling et al., 1995). In addition, HMGBs are 
also involved in the basal transcription via stabilizing the activated conformation 
of the TFIIA, TBP, and TATA element DNA complex (Shykind et al., 1995). The 
second mechanism is the ability of HMGBs to interact directly with nucleosomes 
(Nightingale et al., 1996; Ura et al., 1996). Enrichment of HMGBs instead of 
histone H1 on the entry/exit sites of the nucleosomes, loose the wrapped DNA 
and enhance the accessibility to chromatin-remodeling complexes and other 
transcription factors (Agresti and Bianchi, 2003; Bonaldi et al., 2002; Catez et al., 
2004).  
In addition to activation, HMGBs are also involved in repression of transcription. 
It has been shown that HMGB2 interact with Sp100 and HP1, to form a 
transcriptional repression complex (Lehming et al., 1998). HMGB2 also forms 
complexes with nucleolin and YY1, which bind the D4Z4 repeats located in the 
sub-telomeric region on the long arm of human chromosome 4. The low repeat 
number of D4Z4 leads to increased expression of the entire chromosomal region 
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nearby. It has been shown that binding of YY1, HMGB2 and nucleolin to D4Z4 
contributes to formation of heterochromatin and silence the gene expression 
(Gabellini et al., 2002).  
As mentioned in Chapter 1, tissue-specific expression of genes are usually caused 
by the availability and activity of the transcription factors which specifically 
interact with the cis-elements. Hence, the transcription factors which are 
important for repressing trocarin D expression in non-venom gland tissues and 
unmilked venom gland tissues should have the following characteristics: i) time 
and tissue-specific expression or activity; ii) the specific interaction with the 
corresponding cis-elements; iii) The ability to repress transcription directly or to 
recruit repressor complex to repress transcription indirectly. From the description 
above, YY1, Sp3 and HMGB2 fit all the criteria.  
As mentioned in Chapter 2, YY1, Sp3 and HMGB2 and their binding sites are 
conserved through Drosophila to mammals. Considering their functions, these 
proteins probably account for the tissue-specific expression of TroD in snakes. To 
evaluate the roles of these and other transcription factors, we have sequenced the 
transcriptomes of milked and unmilked venom glands of P. textilis using Next 
Gen Sequencing (data not shown). Preliminary analyses of expression profiles 
showed 100-fold higher expression of YY1 in unmilked venom gland compared 
to milked venom gland (unpublished observations). Thus, it is probable that YY1 




















As limbless animals, snakes have evolved venoms (chemical arsenal) to 
immobilize and capture preys. The origin and evolution of this cocktail of toxins 
is therefore of great interest. One major hypothesis encompasses the duplication 
of a gene encoding a normal ‘physiological’ body protein, which plays important 
role in regulatory processes, and subsequent selective expression and 
neofunctionalization of the duplicate copy in the venom gland (Casewell et al., 
2013; Fry and Wüster, 2004; Fujimi et al., 2002a; Le et al., 2005; Reza et al., 
2005a) . This hypothesis is mainly supported by structural similarities between 
snake venom toxins and physiological counterparts from different organisms. 
Although sharing closely related structures with physiological counterparts, 
several changes that contribute to the toxic characteristics have occurred in toxins 
during their evolution. One of the changes is the alteration in expression pattern: 
from constitutive and low-level expression in non-venom gland tissues 
(physiological counterparts) to inducible and high-level expression in venom 
gland (venom toxins). Recently, the dearth of information on gene sequence and 
expression pattern of physiological counterparts is slowly being overcome by the 
completion of whole genomes, transcriptomes of non-venom gland tissues and 
quantitative analysis of tissue-specific expressions (Castoe et al., 2013; 
Hargreaves et al., 2014; Junqueira-de-Azevedo et al., 2014; Vonk et al., 2013). 
Some of these studies contribute towards our understanding on the origin of toxin 
genes and the tissue-specific expression of toxin and respective cognate genes. 
However, understanding of the regulatory processes, including cis-elements and 
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transcription factors that are involved in their tissue-specific expression, is still 
further away. 
There have been a few studies, which characterized the promoter region of snake 
toxins and evaluated the mechanisms of elevated expression of toxin genes 
(Fujimi et al., 2004; Kwong et al., 2009; Ma et al., 2002). To evaluate the 
relationship between pancreatic and venom PLA2 genes, Tamiya and his 
collaborators analyzed the several gene sequences encoding PLA2 from Laticauda 
semifasciata (Fujimi et al., 2002a, 2002b). The gene sequences for group IA and 
group IB'' PLA2s are 87.7% similar and the absence of pro-peptides in them 
indicates that they arose from a common prototype of group IA, an evolutionary 
intermediate evolved from the ancestral pancreatic PLA2 gene (Fujimi et al., 
2002a). Group IA PLA2 gene is expressed 100-300 times higher in the venom 
gland compared to pancreas, while group IB'' PLA2 gene is expressed at similar 
low levels in both venom gland and pancreas. They found insertions in the 
promoter, the first and second introns of group IA PLA2 gene compared to group 
IB'' PLA2 gene (Fujimi et al., 2002a, 2004). The 411-bp insertion containing two 
E-boxes and a GC-box in the promotor region of group IA PLA2 gene up-
regulates the gene expression by 7-fold in CHOK1 cells (Fujimi et al., 2004), but 
the roles of other inserts are not clear. By comparing the promoter regions of 
alpha-neurotoxin (NTX-2) and cardiotoxin (CTX-2) genes from Naja sputatrix, 
Ma et al. identified a 24-bp silencer element in NTX-2 gene (Ma et al., 2002). 
This element down-regulates NTX-2 gene expression by 4-5 folds in CHOK1 and 
HepG2 cells. They showed that an unidentified 200-kDa protein from venom 
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gland and mammalian cells as a potential transcriptional repressor, which binds to 
the NTX-2 silencer to regulate its expression. 
As mentioned in Chatper 1, we showed that Australian elapid snakes have parallel 
prothrombin activators with distinct physiological roles. Their expression patterns 
support their respective physiological roles; the expression level of trocarin D in 
the venom gland is 30 times higher than that of blood coagulant FX (TrFX) in the 
liver (Reza et al., 2007). The mRNA levels of trocarin D and TrFX are 
undetectable in the liver and venom gland, respectively, even after 24 cycles of 
amplification (Reza et al., 2007). The gene structures of trocarin D and TrFX 
reveal that they have identical numbers of exons and introns and same intron/exon 
boundaries. The gene sequences are highly similar (96.6%), except for one 264 bp 
insertion (VERSE) in the promoter and three insertions and two deletions in intron 
1 regions of trocarin D. Hence, trocarin D derived from its plasma counterpart 
through gene duplication followed by “recruitment”. We showed that 264-bp 
insert (VERSE) in the promoter of trocarin D enhances the expression of 
luciferase in mammalian cells and snake venom gland cells by 19-49-fold 
(Kwong et al., 2009). By systematic deletion and site-directed mutations, we 
identified the roles of TATA box, GATA box and Y-box. Further, we also 
identified three novel cis-elements, two up-regulators and one suppressor, in this 
segment (Kwong et al., 2009).  
So far, intron sequences were used to study the evolutionary relationship between 
different toxin genes (Chang et al., 1997; Doley et al., 2008; Fujimi et al., 2002b; 
Kordis and Gubensek, 1997; Pawlak and Kini, 2008). However, the regulatory 
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role of intron sequences in toxin gene expression is poorly understood. As VERSE 
does not control tissue-specific expression of TroD (Kwong et al., 2009), and 
intron regions are known to contain regulatory cis-elements, we analyzed the role 
of insertions/deletions in the intron 1 in regulating the tissue-specific expression 
of TroD. We found multiple silencing segments located in these 
insertions/deletions, and the most potent ones reside in Ins 2 (1975 bp). From 
1975 bp, we systematically narrowed down silencing cis-elements in multiple 
regions within Ins 2. Among them, a 209 bp segment Ins 2.2.4 is the smallest, 
most potent silencing region, which turns-off (>95%) the gene expression. 
Characterization of the Ins 2.2.4 sequence using bioinformatics tools has revealed 
that it contains five AG-rich motifs. Using luciferase reporter assay, we have 
shown all motifs except for the 5th are important for silencing and that synergism 
between two or more AG-rich motifs is essential for silencing function.  
As transcriptional regulation is achieved by the interactions between cis-elements 
and corresponding transcription factors, I have shown that motifs 1 to 4 form one 
or more specific DNA-transcription factor complexes using electrophoretic 
mobility shift assay (EMSA). Due to sequence similarities, motifs 1-4 form 
similar complexes, but slight sequence differences between motifs contribute to 
their distinct binding potentials for respective specific complexes (Fig. 3-1). As 
motifs 1 and 4 have highest binding affinities for specific complexes, they are 
used as probes to identify specific transcription factors using DNA affinity 
chromatography followed by LC-MS/MS. YY1, Sp3 were identified as specific 
transcription factors for motifs 1 and/or 4, while HMGB2 was identified as non-
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specific AG-rich motif binding protein. I observed consensus binding sequences 
for YY1 (‘CCAT’ or ‘ATGG’ in motifs 1: AGAGAATGGAGA and motif 4: 
AGAGGGTGGAGA), Sp1/3 ('(G/A)(G/A)GG(C/T)G(C/T)' in motif 4: 
AGAGGGTGGAGA) and HMGB2 (‘GAAAA’ in motif 2: AGAAAGGGAAAA) 
(Birnbaum et al., 1995; Hagen et al., 1994; Hyde-DeRuyscher et al., 1995; Lyle et 
al., 1995; Shi et al., 1991). Subsequently, I have shown the repressive functions of 
YY1, Sp3 and HMGB2 (a protein forms repressor complex with YY1) for 
regulating expression of trocarin D by siRNA knockdown in mammalian cells. 
This is the first report that identified transcription factors regulating tissue-
specific expression of snake venom toxin.  
One important feature for characterizing silencing cis-elements is the promoter 
dependency (Maston et al., 2006; Ogbourne and Antalis, 1998). Hence, repressive 
effects of the identified silencing cis-elements in Ins 2.2.4 were evaluated on a 
heterologous CMV promoter. The luciferase assay results revealed the similar 
silencing effects of Ins 2.2.4 on CMV promoter and the VERSE promoter. This 
suggests Ins 2.2.4 is a promoter-independent silencing cis-element that could 
repress expression of other genes as well. Interestingly, further bioinformatics 
analysis of some toxin genes (TroD, PCCS, PLA2 and metalloprotease) and 
housekeeping genes (SDHA, GAPDH, TBP, RPL13A and ACTG1) revealed that 
similar clusters of AG-rich motifs also present in other toxin genes, but not their 
physiological counterparts and housekeeping genes. This suggests that silencing 
cis-elements composed of AG-rich motifs appear to be a class of common 
regulatory elements for venom gland-specific expression of toxin genes.  
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The luciferase assay results from unmilked P. textilis venom gland cells were 
comparable to those from HEK293T, CHOK1 and HepG2 cell lines. This 
suggests that mammalian cell lines are rational substitutes for snake non-venom 
producing cells, including unmilked venom gland cells and non-venom gland 
tissues. As the limited access to primary snake venom gland cells and major 
difficulty in culturing snake non-venom gland cells, it was important to find an 
alternate cellular model for snake non-venom producing cells. Hence, 
characterization of Ins 2.2.4 and corresponding transcription factors were 
performed in mammalian cell lines. 
In conclusion, we have identified multiple silencing elements in insertions of 
trocarin D intron 1 regulating the tissue-specific expression of trocarin D. The 
major functional silencing element Ins2.2.4 contains five AG-rich motifs and 
four-out-of-the-five are important for silencing function and binding of TFs. We 
have also studied the importance of YY1, Sp3 and HMGB2 in repressing gene 
expression. Thus, this study will help us understand possible silencing mechanism 
regulating the tissue-specific expression of trocarin D. Similar AG-rich motifs 
identified in other venom toxin genes may regulate their venom gland-specific 
expression.  
4.2 Limitations 
One limitation in this study is the lack of available snake non-venom gland cell 
lines.  As a result, mammalian cell lines had been used as an alternative model 
system for characterization of regulatory elements and their corresponding 
transcription factors. I have demonstrated that the identified regulatory elements 
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have comparable silencing activity in unmilked venom gland cells as that in 
mammalian cells. Thus, corresponding transcription factors are probably 
conserved in snake and mammalian cells. HEK293T cells were used for purifying 
transcription factors interacting with silencing cis-elements. As described in 
chapter 3, YY1, Sp3 and HMGB2 share highly conserved functional domain 
between Drosophila and human cells. To confirm this, it is possible to use 
antibodies specifically recognize YY1, Sp3 and HMGB2 against the nuclear 
extracts from T. carinatus snake non-venom producing cells. This will further 
support that these transcription factors repress expression of trocarin D in snake 
cells. Another limitation of this study is that the interactions between transcription 
factors and silencing cis-elements were only characterized in vitro using nuclear 
extracts from HEK293T cell line, which may not directly reflect interactions in 
vivo. The interactions in vivo can be confirmed by Chromatin 
ImmunoPrecipitation (ChIP). In ChIP, the transcription factors which bind to the 
chromatin in vivo can be pulled down by specific antibodies from the HEK293T 
cells, and their binding sites can be amplified by PCR. In this way, we can further 
understand the real scenarios in vivo.  
4.3 Future prospects  
It is known that cis-elements are the 'road signs' for the recruitment of 
transcription factors, the executors in the regulation of transcription. We have 
shown that AG-rich motifs share similarity with polycomb response elements and 
bind YY1, Sp3 and HMGB2, which are known as recruiters for polycomb 
repressive complexes. Hence, it is interesting to evaluate whether polycomb 
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repressive complexes play crucial roles in silencing of trocarin D expression. To 
achieve this, we could perform ChIP-PCR for proteins in polycomb repressive 
complexes, and determine if they bind to the identified AG-rich motifs. 
Knockdown assay can also be performed to evaluate the functional role of 
polycomb repressive complexes in silencing expression of trocarin D. In this way, 
we will completely understand how these AG-rich motifs interact with 
transcription factors and repress gene expression. So far, few examples of 
polycomb response elements have been characterized in vertebrates, this study 
will provide another example for this type of regulatory elements, and will 
contribute to understanding of their common sequence characteristics and 
regulatory mechanism.   
We have identified that YY1, Sp3 and HMGB2 repress gene expression through 
binding to the silencing cis-elements in Ins 2.2.4 of trocarin D intron 1 in 
mammalian cell lines. To first figure out whether the results from mammalian cell 
lines are also true in snake cells, ChIP could be performed in snake non-venom 
producing cells (including non-venom gland cells and unmilked venom gland 
cells) as previously described in chapter 4.2. Subsequently, it will be interesting to 
study if the interactions between the identified transcription factors and silencing 
cis-elements disappear in milked venom gland cells. If so, it will be a direct 
evidence to show the identified transcription factors play roles in repressing 
expression of trocarin D. As described in Chapter 1, the interactions between 
transcription factors and cis-elements are regulated by the expression level and 
activity of transcription factors. To understand if the expression levels of YY1, 
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Sp3 and HMGB2 are important for regulating their interactions with the identified 
silencing cis-elements, real-time RT-PCR for those three protein genes could be 
performed in both milked venom gland cells and non-venom producing cells. 
As we know, snake venom toxins are inducibly expressed in the venom gland 
when it is emptied. To initiate/repress the expression, there must be some 
signaling pathways in the venom gland cells which can transfer the active or 
repressive stimulus signal to the corresponding transcription factors, and regulate 
the expression of toxins. In this thesis, we have identified the transcription factors 
and cis-elements which regulate tissue-specific expression of trocarin D.  
However, the upstream signaling pathways which regulate the transcription 
factors are not known. As most of venom toxins have similar expression patterns 
as trocarin D, the regulatory mechanism of trocarin D might be common for 
other venom toxins. To fully understand the regulatory picture of trocarin D and 
other venom toxins, transcriptome of milked and unmilked venom gland cells 
could be compared. In this way, genes which are differentially expressed in 
milked and unmilked venom gland cells will be identified. Based on the gene 
ontology annotations of the differentially expressed genes, we can identify the 
signaling pathways which regulate venom toxins expression. Hence, the complete 
picture of toxin expression regulation will be revealed.  
As AG-rich sequences has long been known to be important for regulating gene 
expression in mammals, and we have identified that these AG-rich motifs also 
present in other snake venom toxin genes but not in their relevant cognate genes. 
It will be intriguing to confirm whether these AG-rich motifs also play roles in 
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regulating venom gland and time-specific expression of other venom toxin genes. 
If this is the case, we will have a good chance to study how these AG-rich motifs 
are recruited to the venom toxin genes and contribute to the different expression 
patterns of venom toxins.  
Last but not least, since the identified silencing cis-elements are functional in 
unmilked venom gland cells, they are probably responsible for the inducible 
expression of trocarin D as well. If those cis-elements could regulate gene 
expression in an inducible manner, it will be promising to use these regulatory 
elements to construct new heterologous expression vectors, which can drive gene 
expression in response to the environmental stimulus. Hence, this can be used in 
gene therapy, in which the gene expression need to be tightly controlled in tissue- 
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